<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Strategies for managing sexual dysfunction induced by antidepressant medication - Taylor, MJ - 2013 | Cochrane Library</title> <meta content="Strategies for managing sexual dysfunction induced by antidepressant medication - Taylor, MJ - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003382.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Strategies for managing sexual dysfunction induced by antidepressant medication - Taylor, MJ - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003382.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003382.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Strategies for managing sexual dysfunction induced by antidepressant medication" name="citation_title"/> <meta content="Matthew J Taylor" name="citation_author"/> <meta content="Institute of Psychiatry, King's College London" name="citation_author_institution"/> <meta content="matthew.j.taylor@kcl.ac.uk" name="citation_author_email"/> <meta content="Lisa Rudkin" name="citation_author"/> <meta content="Bradford Community NHS Trust" name="citation_author_institution"/> <meta content="Philippa Bullemor‐Day" name="citation_author"/> <meta content="Institute of Psychiatry, King's College London" name="citation_author_institution"/> <meta content="Jade Lubin" name="citation_author"/> <meta content="Institute of Psychiatry" name="citation_author_institution"/> <meta content="Christopher Chukwujekwu" name="citation_author"/> <meta content="Coventry and Warwickshire NHS partnership trust" name="citation_author_institution"/> <meta content="Keith Hawton" name="citation_author"/> <meta content="Warneford Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD003382.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003382.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003382.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003382.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antidepressive Agents [*adverse effects, therapeutic use]; Bupropion [therapeutic use]; Carbolines [therapeutic use]; Drug Substitution; Phosphodiesterase 5 Inhibitors [therapeutic use]; Piperazines [therapeutic use]; Purines [therapeutic use]; Randomized Controlled Trials as Topic; Sex Factors; Sexual Dysfunction, Physiological [*chemically induced, *therapy]; Sildenafil Citrate; Sulfones [therapeutic use]; Tadalafil" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003382.pub3&amp;doi=10.1002/14651858.CD003382.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003382\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003382\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003382.pub3",title:"Strategies for managing sexual dysfunction induced by antidepressant medication",firstPublishedDate:"May 31, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003382.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003382.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003382.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003382.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003382.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003382.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003382.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003382.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003382.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003382.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10664 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003382.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-sec1-0006"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/appendices#CD003382-sec1-0012"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/table_n/CD003382StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/table_n/CD003382StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Strategies for managing sexual dysfunction induced by antidepressant medication</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Matthew J Taylor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0003">Lisa Rudkin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0004">Philippa Bullemor‐Day</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0005">Jade Lubin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0006">Christopher Chukwujekwu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information#CD003382-cr-0007">Keith Hawton</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information/en#CD003382-sec1-0016">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003382.pub3">https://doi.org/10.1002/14651858.CD003382.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003382-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003382-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003382-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003382-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003382-abs-0001" lang="en"> <section id="CD003382-abs1-0001"> <h3 class="title" id="CD003382-abs1-0001">Background</h3> <p>Sexual dysfunction (including altered sexual desire, orgasmic and ejaculatory dysfunction, erectile and other problems) is a relatively common side effect of antidepressant medication. These sexual side effects may compromise a person's lifestyle and result in a lack of compliance with the prescribed antidepressant to the detriment of the person's mental health. A wide range of management strategies are possible to address this problem, including behavioural, psychological and pharmacological approaches. </p> </section> <section id="CD003382-abs1-0002"> <h3 class="title" id="CD003382-abs1-0002">Objectives</h3> <p>1. To determine the effectiveness of management strategies for sexual dysfunction caused by antidepressants. </p> <p>2. To determine the adverse effects and acceptability of the different management strategies. </p> </section> <section id="CD003382-abs1-0003"> <h3 class="title" id="CD003382-abs1-0003">Search methods</h3> <p>We searched the Cochrane Depression, Anxiety and Neurosis Group's Specialized Register (CCDANCTR, to 1 January 2013), which includes relevant randomised controlled trials from the following bibliographic databases: The Cochrane Library (all years), EMBASE (1974 to date), MEDLINE (1950 to date) and PsycINFO (1967 to date). Additional searches were carried out by the author team on the same biomedical databases (using terms for 'sexual dysfunction' only) together with CINAHL (1982 to Jan 2012). The reference lists of reports of all included studies were screened. </p> </section> <section id="CD003382-abs1-0004"> <h3 class="title" id="CD003382-abs1-0004">Selection criteria</h3> <p>We included randomised controlled trials that compared management strategies for antidepressant‐induced sexual dysfunction versus placebo or any alternative strategy. </p> </section> <section id="CD003382-abs1-0005"> <h3 class="title" id="CD003382-abs1-0005">Data collection and analysis</h3> <p>Two authors independently extracted data and assessed trial quality. Study authors were contacted for additional information. </p> </section> <section id="CD003382-abs1-0006"> <h3 class="title" id="CD003382-abs1-0006">Main results</h3> <p>We included 23 trials involving 1886 people in this updated review. Twenty‐two of these trials investigated the addition of medication to treat the identified dysfunction, with most agents studied in only single studies. One study investigated switching to an alternative antidepressant. </p> <p>In men, data for the phosphodiesterase inhibitors sildenafil (three studies, 255 participants) and tadalafil (one study, 54 participants) indicated they led to a greater improvement in erectile function than placebo. Combined data from three sildenafil studies found benefit over placebo on International Index of Erectile Function ratings of ability to achieve (MD 1.04, 95% CI 0.65 to 1.44), and maintain erections (MD 1.18, 95% CI 0.78 to 1.59). A single point improvement on these ratings is equivalent to an improvement in frequency from 'sometimes' to 'most times'. Men receiving tadalafil were more likely to report improved erectile function (RR 11.50, 95% CI 3.03 to 43.67). For women it remains uncertain whether sildenafil is more effective than placebo. Unpublished data could reduce this uncertainty. </p> <p>Data from three studies in men and women of bupropion 150 mg twice daily indicate a benefit over placebo on rating scale scores (SMD 1.60, 95% CI 1.40 to 1.81), but response rates in two studies of bupropion 150 mg once daily demonstrated no statistically significant difference in effect (RR 0.62, 95% CI 0.09 to 4.41). </p> <p>Other augmentation strategies failed to demonstrate significant improvements in sexual dysfunction compared with placebo. </p> <p>One trial involving 75 people with sexual dysfunction due to sertraline assessed the effect of changing antidepressant. Switching to nefazodone was significantly less likely to result in the re‐emergence of sexual dysfunction than restarting sertraline (RR 0.34, 95% CI 0.19 to 0.60), however, nefazodone is no longer available for clinical use. </p> <p>There is an absence of randomised trials assessing the effects of switching to currently‐available antidepressant agents with lower rates of adverse sexual effects, the role of psychological or mechanical interventions, or of techniques such as drug holidays. </p> <p>We identified no data for any of the strategies included in the trials assessed that indicated that they led to a worsening of psychiatric symptoms. However, the relatively small numbers assessed for many of the interventions studied means that the possibility of such an effect cannot confidently be excluded in all cases. </p> <p>Given the small numbers of studies assessing most of the strategies assessed, the presence of any unpublished trials could have substantial effects on estimates of effect. In some cases, only results from particular items or subscales within ratings scales are available. It is likely that this could act to bias estimates of effect obtained, increasing apparent effectiveness. </p> </section> <section id="CD003382-abs1-0007"> <h3 class="title" id="CD003382-abs1-0007">Authors' conclusions</h3> <p>The evidence currently available is rather limited. For men with antidepressant‐induced erectile dysfunction, the addition of sildenafil or tadalafil appears to be an effective strategy. For women with antidepressant‐induced sexual dysfunction the addition of bupropion at higher doses appears to be the most promising approach studied so far. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003382-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003382-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003382-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003382-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD003382-abs-0005">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003382-abs-0004" lang="en"> <h3>Strategies for managing sexual dysfunction caused by antidepressants</h3> <p>Antidepressants can have numerous effects on sexual function including altered sexual desire, erection difficulties and orgasm problems. This systematic review investigated different ways to manage such sexual dysfunction. We included 23 randomised studies, with a total of 1886 participants who had developed their sexual problems while taking antidepressant medication. Twenty‐two of these studies looked at the addition of further medication to the ongoing treatment for depression. For men with antidepressant‐induced erectile dysfunction, the addition of sildenafil (Viagra; three studies, 255 participants) or tadalafil (Cialis; one study, 54 participants) appeared to improve the situation. For women with antidepressant‐induced sexual dysfunction the addition of bupropion (Wellbutrin, Zyban; three studies, 482 participants) at higher doses appears to be the most promising approach studied so far, but further data from randomised trials are likely to be required before it can be recommended confidently. We did not find evidence that any intervention led to a worsening of psychiatric symptoms; however, we cannot be confident of this for many of the interventions studied, as only small numbers of participants have been studied so far. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003382-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003382-sec1-0007"></div> <h3 class="title" id="CD003382-sec1-0008">Implications for practice</h3> <section id="CD003382-sec1-0008"> <p>The evidence currently available is rather limited. For men with antidepressant‐induced erectile dysfunction, the addition of sildenafil or tadalafil appears to be an effective strategy, and there are some promising data for bupropion. For women with antidepressant‐induced sexual dysfunction, the addition of bupropion at higher doses appears to be the most promising approach studied so far. </p> </section> <h3 class="title" id="CD003382-sec1-0009">Implications for research</h3> <section id="CD003382-sec1-0009"> <p>Further randomised trials are required. There is a particular need for more evidence to guide treatment of antidepressant‐induced sexual dysfunction in women. Addition of bupropion to existing treatment warrants further study. Randomised trials could assess approaches for which there is currently an absence of evidence, including: switching to currently‐available antidepressant agents with lower rates of sexual adverse effects, the role of psychological or mechanical interventions, or of techniques such as drug holidays. Outcome assessments using standardised ratings scales should be included. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003382-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003382-sec1-0001"></div> <div class="table" id="CD003382-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sildenafil versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sildenafil compared with placebo for antidepressant‐induced sexual dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with antidepressant‐induced sexual dysfunction </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> sildenafil </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (no of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Sildenafil</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) total scores</b> </p> <p>(The IIEF is a self‐report measure with 15 questions examining erectile function, orgasmic function, sexual desire, and intercourse satisfaction. Maximum possible score 75) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IIEF score ranged across control groups from <br/> 40.9 to 44.2 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IIEF score in the intervention groups was <br/> 19.36 higher (15.00 to 23.72 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 men <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) scores ‐ question 3: ability to achieve erection</b> </p> <p>(Maximum score 5)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in control groups was 3.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention groups was <br/> 1.04 higher (0.65 to 1.44 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>231 men <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) scores ‐ intercourse satisfaction (questions 6, 7, 8)</b> </p> <p>(Maximum score 15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the control group was 7.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention group was <br/> 3.50 higher (2.48 to 4.52 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89 men <br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clinical Global Impression ‐Sexual Function not "much/very much improved" by endpoint</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Male population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 0.44 (0.33 to 0.58) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>187 <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>956 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>459 per 1000</b> <br/> (325 to 630) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Female population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>735 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>287 per 1000</b> <br/> (176 to 456) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Dropouts</b> </p> <p>(People leaving the trial early)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR</b> 0.68 (0.41 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>353 <br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (37 to 103) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b> <br/> (102 to 285) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>360 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> <br/> (148 to 411) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Global Efficacy Questionnaire (questions 1 &amp; 2)</b> </p> <p>(Questions assessing improvement attributed to medication compared to having no treatment at all) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Improvement in erections</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 2.50 (1.67 to 3.73) </p> <p>and</p> <p><b>RR</b> 2.55 (1.71 to 3.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>284 men <br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>282 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>705 per 1000</b> <br/> (470 to 1000) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Improvement in ability to have sexual intercourse</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>282 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>719 per 1000</b> <br/> (482 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The evidence for effects based on single trials is rated as moderate quality since further trial data may well change the estimate. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003382-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Bupropion versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Bupropion compared with placebo for antidepressant‐induced sexual dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with antidepressant‐induced sexual dysfunction </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> bupropion (doses of 150 mg daily and 150 mg twice daily) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (no of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Bupropion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint scale total scores (150 mg twice daily dose)</b> </p> <p>(Scales of sexual functioning. As studies used different scales to assess sexual functioning, differences are expressed as standardised mean differences (SMD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean value with this analysis is in effect zero</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention groups was 1.60 higher (1.40 to 1.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>482 <br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>50% reduction in score on the Arizona Sexual Experiences Scale (ASEX) (150 mg once daily dose)</b> </p> <p>(The ASEX is a 5‐item self‐report inventory of sexual function)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Lower risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 0.62 (0.09 to 4.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>71 <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (4 to 208) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Higher risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (6 to 296) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Dropouts</b> </p> <p>(People leaving the trial early)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Lower risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 1.08 (0.67 to 1.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>579 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> <br/> (60 to 155) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Higher risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b> <br/> (100 to 258) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Unexplained inconsistency in effects between studies reduces confidence in this effect </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003382-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003382-sec1-0002"></div> <section id="CD003382-sec2-0001"> <h3 class="title" id="CD003382-sec2-0001">Description of the condition</h3> <p>Antidepressant medications are widely prescribed (<a href="./references#CD003382-bbs2-0065" title="DonoghueJM , TyleeA . The treatment of depression: prescribing patterns of antidepressants in primary care. British Journal of Psychiatry1996;168:164‐8. ">Donoghue 1996</a>; <a href="./references#CD003382-bbs2-0077" title="JickS , DeanA , JickH . Antidepressants and suicide. BMJ1995;310:215‐8. ">Jick 1995</a>; <a href="./references#CD003382-bbs2-0083" title="Moore M ,  YuenHM ,  DunnN ,  MulleeMA ,  MaskellJ ,  KendrickT . Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ2009;339:b3999. [PUBMED: 19833707] ">Moore 2009</a>). Sexual dysfunction is a common, well‐known adverse effect of all antidepressants (<a href="./references#CD003382-bbs2-0058" title="BalonR . Sexual dysfunction during antidepressant treatment. Journal of Clinical Psychiatry1993;54:209‐12. ">Balon 1993</a>; <a href="./references#CD003382-bbs2-0056" title="BaldwinDS , ThomasSC , BirtwistleJ . Effects of antidepressant drugs on sexual function. International Journal of Psychiatry in Clinical Practice1997;1:47‐58. ">Baldwin 1997</a>; <a href="./references#CD003382-bbs2-0093" title="Williams VS ,  Baldwin DS , HogueSL , FehnelSE , HollisKA , EdinHM . Estimating the prevalence and impact of antidepressant‐induced sexual dysfunction in 2 European countries: a cross‐sectional patient survey. Journal of Clinical Psychiatry2006;67:204‐10. [PUBMED: 16566614] ">Williams 2006</a>; <a href="./references#CD003382-bbs2-0094" title="Williams VS , EdinHM , HogueSL , FehnelSE ,  Baldwin DS . Prevalence and impact of antidepressant‐associated sexual dysfunction in three European countries: replication in a cross‐sectional patient survey. Journal of Psychopharmacology2010;24:489‐96. [PUBMED: 19329551] ">Williams 2010</a>). These sexual adverse effects can affect a person's lifestyle considerably, and, where this results in reduced compliance with medication, lead to less effective treatment of the primary psychiatric disorder. </p> <p>Several different types of sexual dysfunction may be related to antidepressants, including altered sexual desire ‐ such as loss or lack of desire; orgasmic and ejaculatory dysfunction, including anorgasmia (inability to achieve orgasm), hyperorgasmia (significantly more orgasms in a short time period than normal), painful orgasm and inhibited ejaculation; erectile problems, including erectile dysfunction (impotence), priapism (significantly prolonged erection) and painful erection ‐ and other issues, including problems of sexual arousal, reduced sexual satisfaction, lubrication, dyspareunia (painful intercourse) and vaginismus (tensing of vaginal muscles that make intercourse painful or impossible). </p> <p>Identifying antidepressant‐induced sexual dysfunction can be complicated by the association of sexual dysfunction with some disorders that antidepressants are used to treat. For example, depression is associated with increased rates of reported sexual dysfunction even when no treatment is received (<a href="./references#CD003382-bbs2-0055" title="AngstJ . Sexual problems in healthy and depressed persons. International Clinical Psychopharmacology1998;13S6:S1‐4. [MEDLINE: 9728667] ">Angst 1998</a>). </p> <p>Sexual dysfunction has been reported with all classes of antidepressant medication. Reported rates of sexual dysfunction are typically underestimates, as sexual adverse effects are often not specifically asked about in treatment trials, while direct questioning can reveal higher rates than are reported spontaneously (<a href="./references#CD003382-bbs2-0081" title="Montejo‐GonzalezAL , LlorcaG , IzquierdoJA . SSRI‐induced sexual dysfunction: fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective, multicentre and descriptive clinical study of 344 patients. Journal of Sex &amp; Marital Therapy1997;23:176‐94. ">Montejo‐Gonzalez 1997</a>). Studies of the prevalence of antidepressant‐induced sexual dysfunction have exhibited a number of methodological problems (<a href="./references#CD003382-bbs2-0082" title="MontgomerySA , BaldwinDS , RileyA . Antidepressant medications: a review of the evidence for drug‐induced sexual dysfunction. Journal of Affective Disorders2002;69:119‐40. ">Montgomery 2002</a>). These include the frequent absence of comparison groups or baseline assessments, and inconsistent definitions of sexual dysfunction between studies. </p> <p>The majority of studies directly comparing rates of sexual dysfunction between different antidepressants have involved selective serotonin reuptake inhibitors (SSRIs). Generally, trials have reported no significant differences between these drugs in rates of sexual dysfunction, with sexual dysfunction reported in population surveys by over one third of participants (<a href="./references#CD003382-bbs2-0093" title="Williams VS ,  Baldwin DS , HogueSL , FehnelSE , HollisKA , EdinHM . Estimating the prevalence and impact of antidepressant‐induced sexual dysfunction in 2 European countries: a cross‐sectional patient survey. Journal of Clinical Psychiatry2006;67:204‐10. [PUBMED: 16566614] ">Williams 2006</a>; <a href="./references#CD003382-bbs2-0094" title="Williams VS , EdinHM , HogueSL , FehnelSE ,  Baldwin DS . Prevalence and impact of antidepressant‐associated sexual dysfunction in three European countries: replication in a cross‐sectional patient survey. Journal of Psychopharmacology2010;24:489‐96. [PUBMED: 19329551] ">Williams 2010</a>). In randomised trials, nefazodone (a serotonin antagonist and reuptake inhibitor) and bupropion (a norepinephrine‐dopamine reuptake inhibitor) have been associated with less sexual dysfunction than the SSRI, sertraline (<a href="./references#CD003382-bbs2-0064" title="CroftH , SettleEJr , HouserT , BateySR , DonahueRM , AscherJA . A placebo‐controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained‐release bupropion and sertraline. Clinical Therapeutics1999;21:643‐58. [MEDLINE: 10363731] ">Croft 1999</a>; <a href="./references#CD003382-bbs2-0066" title="FeigerA , KievA , ShrivastavaRK , WisselinkPG , WilcoxCS . Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. Journal of Clinical Psychiatry1996;57 Suppl 2:53‐62. [MEDLINE: 8626364] ">Feiger 1996</a>), and reboxetine (a norepinephrine reuptake inhibitor) with greater sexual satisfaction than the SSRI fluoxetine (<a href="./references#CD003382-bbs2-0063" title="ClaytonAH , ZajeckaJ , FergusonJM , Filipiak‐ReisnerJK , BrownMT , SchwartzGE . Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. International Clinical Psychopharmacology2003;18:151‐6. ">Clayton 2003</a>). The monoamine oxidase inhibitor, moclobemide, was more commonly associated with increased sexual desire than the tricyclic antidepressant, doxepin (<a href="./references#CD003382-bbs2-0084" title="PhilippM , KonhenR , BenkertO . A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. International Clinical Psychopharmacology1993; Vol. 7:149‐53. [MEDLINE: 8468436] ">Philipp 1993</a>). Further information on rates of sexual dysfunction with antidepressants can be found elsewhere (<a href="./references#CD003382-bbs2-0069" title="GregorianRS , GoldenKA , BahceA , GoodmanC , KwongWJ , KhanZM . Antidepressant‐induced sexual dysfunction. Annals of Pharmacotherapy2002;36:1577‐89. [MEDLINE: 12243609] ">Gregorian 2002</a>; <a href="./references#CD003382-bbs2-0082" title="MontgomerySA , BaldwinDS , RileyA . Antidepressant medications: a review of the evidence for drug‐induced sexual dysfunction. Journal of Affective Disorders2002;69:119‐40. ">Montgomery 2002</a>; <a href="./references#CD003382-bbs2-0088" title="SerrettiA ,  ChiesaA . Treatment‐emergent sexual dysfunction related to antidepressants: a meta‐analysis. Journal of Clinical Psychopharmacology2009;29:259‐66. [PUBMED: 19440080] ">Serretti 2009</a>). </p> </section> <section id="CD003382-sec2-0002"> <h3 class="title" id="CD003382-sec2-0002">Description of the intervention</h3> <p>Management strategies described for the treatment of antidepressant‐induced sexual dysfunction include waiting for the problem to resolve; behavioural strategies modifying sexual technique; individual and couple psychotherapy; alterations of antidepressant usage, including reducing dose; delaying use until after sexual activity; 'drug holidays'; switching to a different antidepressant; and the use of additional agents (<a href="./references#CD003382-bbs2-0057" title="BaldwinDS . Sexual dysfunction associated with antidepressant drugs.. Expert Opinion on Drug Safety2004;3:457‐70. [PUBMED: 15335301] ">Baldwin 2004</a>). A wide range of additional agents have been employed clinically to try to reverse this problem, for example erectile dysfunction might be treated with a phosphodiesterase inhibitor such as sildenafil or tadalafil. However, additional treatments may themselves have adverse effects and tolerability problems, and could, in theory, affect the primary psychiatric condition for which the antidepressants were prescribed. </p> </section> <section id="CD003382-sec2-0003"> <h3 class="title" id="CD003382-sec2-0003">How the intervention might work</h3> <p>The mechanisms by which antidepressants cause sexual dysfunction involve complex multi‐system interactions, which are not entirely understood. Psychological factors such as anxiety may also play a role in maintaining dysfunction. The main neurotransmitters involved are serotonin (5HT), acetylcholine, noradrenaline, and dopamine. The adverse sexual effects may be caused centrally or peripherally and may result from the change in function of one or more neurotransmitter. Given this complex system, additional treatments employed have had a wide variety of putative mechanisms. Such treatments have included sildenafil (a phosphodiesterase inhibitor), amantadine (a dopamine agonist), cyproheptadine (an antihistamine and 5HT blocker), yohimbine (an alpha‐2 blocker), buspirone (a 5HT1A receptor agonist), bethanechol (an acetylcholine agonist) and <i>Ginkgo biloba</i> (a herbal medication). </p> </section> <section id="CD003382-sec2-0004"> <h3 class="title" id="CD003382-sec2-0004">Why it is important to do this review</h3> <p>This is an update of a Cochrane review first published in 2004. That review noted that the available evidence was rather limited, with small numbers of trials assessing each strategy. This review aims to summarise the current evidence regarding potential strategies for managing antidepressant‐induced sexual dysfunction, noting how well the sexual dysfunction responds, as well as risks, such as adverse effects or worsening of the condition for which the antidepressant was initially prescribed. This should assist patients and their clinicians when deciding how best to manage these common problems. </p> <p>Attention is drawn to the related Cochrane review on the management of sexual dysfunction due to antipsychotic drug therapy (<a href="./references#CD003382-bbs2-0060" title="BernerMM , HagenM , KristonL , OmarH . Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003546.pub2] ">Berner 2007</a>; <a href="./references#CD003382-bbs2-0087" title="SchmidtHM ,  HagenM ,  KristonL ,  Soares‐WeiserK ,  MaayanN ,  BernerMM . Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database of Systematic Reviews2012, Issue 11. [CD003546; PUBMED: 23152218] ">Schmidt 2012</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003382-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003382-sec1-0003"></div> <p>1. To determine the effectiveness of management strategies for sexual dysfunction caused by antidepressants. </p> <p>2. To determine the adverse effects and acceptability of the different management strategies. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003382-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003382-sec1-0004"></div> <section id="CD003382-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003382-sec3-0001"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials in the review. Cluster randomised trials and trials of both parallel group and cross‐over design were considered suitable for inclusion.Trials using non‐randomised allocation were not included, in order to reduce risks of selection and publication bias (<a href="./references#CD003382-bbs2-0053" title="AldersonP , GreenS , HigginsJPT , editors. Cochrane Reviewers' Handbook 4.2.2 [updated March 2004] The Cochrane Library. Chichester, UK: John Wiley &amp; Sons, Ltd. ">Alderson 2004</a>). </p> </section> <section id="CD003382-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Patients aged 16 years and over with sexual dysfunction (including, but not restricted to altered sexual desire, orgasmic and ejaculatory dysfunction, erectile problems, problems of sexual arousal, reduced sexual satisfaction, lubrication, dyspareunia and vaginismus).as a result of being treated with an antidepressant (except mood stabilisers) on any dose regime. </p> <p>Participants from inpatient or community settings were eligible for inclusion.</p> <p>Inclusion was not restricted on the basis of the disorder for which the antidepressant had been prescribed. </p> </section> <section id="CD003382-sec3-0003"> <h4 class="title">Types of interventions</h4> <section id="CD003382-sec4-0001"> <h5 class="title">Experimental intervention</h5> <p>Any management strategy ‐ pharmacological, psychological or otherwise ‐ for antidepressant‐induced sexual dysfunction. </p> </section> <section id="CD003382-sec4-0002"> <h5 class="title">Comparator intervention</h5> <p>Placebo or any alternative strategy.</p> </section> </section> <section id="CD003382-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD003382-sec4-0003"> <h5 class="title">Primary outcomes</h5> <p>1. Changes, or post‐treatment differences, in the severity of the identified sexual dysfunction (assessed by self (self‐rated measures) or interviewer (interviewer‐rated measures), or both. </p> </section> <section id="CD003382-sec4-0004"> <h5 class="title">Secondary outcomes</h5> <p>2. Changes, or post‐treatment differences, in sexual satisfaction and functioning (based on self‐ or interviewer‐rated measures, or both). <br/> 3. Dropout rates as a measure of the acceptability of specific therapies. <br/> 4. Change, or post‐treatment differences, in the primary psychiatric condition for which the antidepressant was being prescribed (based on symptom ratings). </p> <p>Outcomes at trial endpoint were employed, where available. No decision was made to favour self‐reported or interviewer‐rated measures. </p> </section> </section> </section> <section id="CD003382-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003382-sec3-0005"> <h4 class="title">CCDAN's Specialized Register (CCDANCTR)</h4> <p>The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) maintains two clinical trials registers at the editorial base (Bristol, UK), a references register and a studies‐based register. The CCDANCTR‐References Register contains over 29,500 reports of randomised controlled trials in depression, anxiety and neurosis. Approximately 65% of these references have been tagged to individual, coded trials. The coded trials are held in the CCDANCTR‐Studies Register and records are linked between the two registers through the use of unique Study ID tags. Coding of trials is based on the EU‐Psi coding manual. Please contact the CCDAN Trials Search Co‐ordinator for further details. Reports of trials for inclusion in the Group's registers are collated from routine (weekly), generic searches of MEDLINE (1950 to date), EMBASE (1974 to date) and PsycINFO (1967 to date); quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and review‐specific searches of additional databases. Reports of trials are also sourced from international trials registers c/o the World Health Organization's trials portal (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>), drug companies, the handsearching of key journals, conference proceedings and other (non‐Cochrane) systematic reviews and meta‐analyses. Details of <a href="http://ccdan.cochrane.org/search-strategies-identification-studies" target="_blank">CCDAN's generic search strategies</a> can be found on the Group's website. </p> </section> <section id="CD003382-sec3-0006"> <h4 class="title">Electronic searches</h4> <p>Electronic searches included:</p> <p>1. The CCDANCTR‐Studies Register (all years to 1 August 2012, with a further update search for 1 January 2013), using the following coding terms: <br/> Condition = ( “sexual dysfunction*” and “drug induced”) or Comorbidity = (“sexual dysfunction*”). </p> <p>2. The CCDANCTR‐References Register, using a more sensitive set of free‐text terms to find additional untagged/uncoded references (<a href="./appendices#CD003382-sec2-0016">Appendix 1</a>). </p> <p>3. Independent searches by the author team on the Cochrane Register of Controlled Trials (CENTRAL) (2012, Issue 1), CINAHL (1982 to 12 January 2012), EMBASE (1980 to 12 January 2012), MEDLINE (1966 to 12 January 2012) and PsycINFO (1984 to 12 January 2012) (<a href="./appendices#CD003382-sec2-0017">Appendix 2</a>). </p> <p>4. International trials registries (<a href="http://www.clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and <a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">ICTRP</a>, 1 January 2013), to identify additional ongoing or unpublished studies . </p> </section> <section id="CD003382-sec3-0007"> <h4 class="title">Searching other resources</h4> <section id="CD003382-sec4-0005"> <h5 class="title">Reference checking</h5> <p>The reference lists of all trials identified for inclusion were examined, together with other articles on adverse sexual effects of antidepressants, and relevant conference proceedings. </p> </section> <section id="CD003382-sec4-0006"> <h5 class="title">Personal communications</h5> <p>The following experts in the field of sexology were contacted for the original review: J Bancroft, R Basson, J Heiman and R Rosen. </p> </section> <section id="CD003382-sec4-0007"> <h5 class="title">Pharmaceutical companies</h5> <p>For the original review, the authors contacted pharmaceutical companies manufacturing antidepressant medication to find out if they knew of any published or unpublished studies relevant to this review. This search was not repeated for the update. </p> </section> </section> </section> <section id="CD003382-sec2-0007"> <h3 class="title" id="CD003382-sec2-0007">Data collection and analysis</h3> <section id="CD003382-sec3-0008"> <h4 class="title">Selection of studies</h4> <p>Trial inclusion or exclusion was determined independently by two authors. Full reports of studies were used for this assessment, except where a trial could be excluded on the basis of title and abstract alone. Any disagreements were resolved by consensus discussion with a third member of the review team. </p> </section> <section id="CD003382-sec3-0009"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted from the included studies about participants' characteristics, intervention details (including whether or not the study was of a discontinuation design) and outcome measures. The data were extracted independently by two authors. Where inadequate trial data were provided, the authors were contacted in order to obtain further information. Where standard deviations were not reported but could be calculated from standard errors this was done in conventional fashion (Cochrane Handbook chapter 7.7.3.3 <a href="./references#CD003382-bbs2-0075" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009].The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>). Any disagreements were resolved by consensus discussion with a third member of the review team. </p> <section id="CD003382-sec4-0008"> <h5 class="title">Main planned comparisons</h5> <p>We planned to compare each experimental intervention with placebo or alternative comparator intervention, and, where possible, to group comparisons of interventions with similar mechanisms. </p> </section> </section> <section id="CD003382-sec3-0010"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors independently assessed the methodological quality of the included studies using the Cochrane Collaboration tool for risk of bias (<a href="./references#CD003382-bbs2-0076" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>)<i>.</i> Any disagreements were resolved by consensus discussion with a third member of the review team. The risk of bias tool assesses seven domains namely: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and ‘other issues’. Each domain is assigned one of the following judgements: ‘low risk’ of bias, ‘high risk’ of bias, or ‘unclear risk’ of bias, and a supporting statement is provided to back up the judgement. </p> </section> <section id="CD003382-sec3-0011"> <h4 class="title">Measures of treatment effect</h4> <p>Data were analysed using Review Manager software (version 5.2). For binary efficacy outcomes, a pooled risk ratio (with 95% confidence intervals) was calculated using a fixed‐effect model. Risk ratios are reported since this measure can be more readily applied in clinical practice (<a href="./references#CD003382-bbs2-0086" title="SackettDL , DeeksJJ , AltmanDG . Down with odds ratios!. Evidence Based Medicine1996;1:164‐6. ">Sackett 1996</a>; <a href="./references#CD003382-bbs2-0089" title="SinclairJC , BrakenMB . Clinically useful measures of effect in binary analyses of randomised trials. Journal of Clinical Epidemiology1994;47:881‐9. ">Sinclair 1994</a>). For continuously distributed outcomes, the mean difference (MD) was calculated when the same scale was used by all studies. Standardised mean difference was employed for comparisons across different scales. </p> <p>We extracted outcome data collected from any time point, but our reported analyses use trial endpoint data, except where specified. Differences between trials in the times of assessment are reported. </p> </section> <section id="CD003382-sec3-0012"> <h4 class="title">Unit of analysis issues</h4> <section id="CD003382-sec4-0009"> <h5 class="title">Cluster‐randomised trials</h5> <p>The review protocol did not address how we would include data from cluster‐randomised trials. Although none have been encountered in this review, the appropriate methods, should they need to be included, will be included in a future update of this review. </p> </section> <section id="CD003382-sec4-0010"> <h5 class="title">Cross‐over trials</h5> <p>We intended to use data from the first period of treatment only for cross‐over trials, but we did use pooled data from both periods where these were the only data available. </p> </section> <section id="CD003382-sec4-0011"> <h5 class="title">Studies with multiple treatment groups</h5> <p>Where studies included multiple treatment groups, pair‐wise comparisons are reported. This may lead to increased correlation between estimated intervention effects across such comparisons, as described in the Cochrane Handbook. Where possible, groups were combined to create a single pair‐wise comparison or alternatively the ‘shared’ control group data were split into two or more groups with smaller sample size(s). </p> </section> </section> <section id="CD003382-sec3-0013"> <h4 class="title">Dealing with missing data</h4> <p>We used trial data from intention‐to‐treat analyses when available. Where this was not possible, we used endpoint data for the participants who completed the trial. Where necessary, we wrote to study authors to request missing data. </p> </section> <section id="CD003382-sec3-0014"> <h4 class="title">Assessment of heterogeneity</h4> <p>Statistical heterogeneity between studies was assessed using the I<sup>2</sup> statistic. The Cochrane Handbook suggests interpretation of an I<sup>2</sup> of 0% to 40% as being potentially unimportant heterogeneity, 30% to 60% as representing moderate heterogeneity, 50% to 90% indicating substantial heterogeneity, and 75% to 100% indicating considerable heterogeneity (<a href="./references#CD003382-bbs2-0074" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. [DOI: 10.1136/bmj.327.7414.557] ">Higgins 2003</a>). </p> </section> <section id="CD003382-sec3-0015"> <h4 class="title">Assessment of reporting biases</h4> <p>We considered methods to look for evidence of small study bias, but the number of trials identified for each comparison was too limited for this to be appropriate. Should the number of trials available increase in future updates of this review, the use of methods such as funnel plots and statistical tests to identify possible publication bias will be considered. </p> </section> <section id="CD003382-sec3-0016"> <h4 class="title">Data synthesis</h4> <p>Fixed‐effect analyses are presented unless otherwise stated. Random‐effects models were used routinely to investigate the sensitivity of results to the choice of statistical method, but we observed no cases where this altered estimates of effect qualitatively. </p> </section> <section id="CD003382-sec3-0017"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were planned by:</p> <p>1. Gender of those experiencing sexual dysfunction (men only, women only, mixed group).</p> <p>2. Dose of intervention.</p> </section> <section id="CD003382-sec3-0018"> <h4 class="title">Sensitivity analysis</h4> <p>Possible sensitivity analyses were considered to assess the impact of differences in study methodology on outcomes, but no such analyses were performed in view of the small numbers of trials identified for each intervention. </p> <section id="CD003382-sec4-0012"> <h5 class="title">'Summary of findings' table</h5> <p>As this review addresses more than one major treatment comparison, separate 'Summary of findings' tables were prepared for interventions where data were available from three or more trials. Outcome data were summarised separately by gender, where possible. Assumed baseline risks were taken from median control group risks across included studies. Quality of evidence used was assessed using the specific evidence grading system developed by the GRADE working group (<a href="./references#CD003382-bbs2-0068" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328:1490. [DOI: 10.1136/bmj.328.7454.1490] ">GRADE working group 2004</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003382-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003382-sec1-0005"></div> <section id="CD003382-sec2-0008"> <h3 class="title">Description of studies</h3> <section id="CD003382-sec3-0019"> <h4 class="title">Results of the search</h4> <p>Over 6000 citations were identified by the search strategy of this review (<a href="#CD003382-fig-0001">Figure 1</a>). Of these, 70 citations appeared potentially relevant and 23 were included, 22 of which provided data for quantitative analysis. </p> <div class="figure" id="CD003382-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD003382-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>Further information was provided by the authors of several studies (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>; <a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>; <a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0010" title="JacobsenFM , Comas‐DiazL . A double‐blind placebo‐controlled trial of yohimbine for treatment of SRI‐induced sexual dysfunction. 149th Annual Meeting of the American Psychiatric Association. 1996. ">Jacobsen 1996</a>; <a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). </p> </section> <section id="CD003382-sec3-0020"> <h4 class="title">Included studies</h4> <section id="CD003382-sec4-0013"> <h5 class="title">Design</h5> <p>We identified 23 studies that met the inclusion criteria for this review (see <a href="./references#CD003382-sec2-0020" title="">Characteristics of included studies</a>). Some additional studies were identified too late for inclusion in this version of the review, and so are awaiting classification (see <a href="./references#CD003382-sec2-0022" title="">Characteristics of studies awaiting classification</a>). If suitable, they will be included in a future update of the review. </p> <p>Nineteen studies were of parallel‐group design, and three used a cross‐over design (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>; <a href="./references#CD003382-bbs2-0014" title="AhroldTK , MestonCM . Effects of SNS activation on SSRI‐induced sexual side effects differ by SSRI. Journal of Sex &amp; Marital Therapy2009;35:311‐9. [CENTRAL: CN‐00706808; PUBMED: 19466669] MestonCM . A randomized, placebo‐controlled, crossover study of ephedrine for SSRI‐induced female sexual dysfunction. Journal of Sex &amp; Marital Therapy2004;30:57‐68. ">Meston 2004</a>; <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a>). Length of included trials ranged from 14 days to 26 weeks. Where trials described a period of randomised treatment followed by a non‐randomised period, we have reported only the period of randomised treatment. </p> </section> <section id="CD003382-sec4-0014"> <h5 class="title">Sample sizes</h5> <p>Numbers of people randomised within individual studies varied greatly from 12 participants (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>; <a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>), to 288 (<a href="./references#CD003382-bbs2-0001" title="BaldwinD , HutchisonJ , DonaldsonK , ShawB , SmithersA . Selective serotonin re‐uptake inhibitor treatment‐emergent sexual dysfunction: randomized double‐blind placebo‐controlled parallel‐group fixed‐dose study of a potential adjuvant compound, VML‐670. Journal of Psychopharmacology2008;22(1):55‐63. [CENTRAL: CN‐00627684; PUBMED: 17715211] ">Baldwin 2008</a>). This update adds new data from several studies with over 100 participants (<a href="./references#CD003382-bbs2-0001" title="BaldwinD , HutchisonJ , DonaldsonK , ShawB , SmithersA . Selective serotonin re‐uptake inhibitor treatment‐emergent sexual dysfunction: randomized double‐blind placebo‐controlled parallel‐group fixed‐dose study of a potential adjuvant compound, VML‐670. Journal of Psychopharmacology2008;22(1):55‐63. [CENTRAL: CN‐00627684; PUBMED: 17715211] ">Baldwin 2008</a>; <a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). </p> </section> <section id="CD003382-sec4-0015"> <h5 class="title">Setting</h5> <p>Participants were recruited to studies taking place in a range of countries. The greatest number of studies took place in the USA and Europe, but studies were identified from South Korea (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>), and South Africa (<a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>), with two large new studies from Iran (<a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>, <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). </p> </section> <section id="CD003382-sec4-0016"> <h5 class="title">Participants</h5> <p>The total number of participants randomised in the 23 studies was 1886.</p> <p>Participants in 12 of the studies had developed adverse sexual effects from the use of a selective serotonin reuptake inhibitor (SSRI). Two participants in one study had received nortriptyline, a tricyclic antidepressant (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>). One study did not specify the type of antidepressant involved (<a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>). </p> <p>Seven studies included only women (<a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>; <a href="./references#CD003382-bbs2-0014" title="AhroldTK , MestonCM . Effects of SNS activation on SSRI‐induced sexual side effects differ by SSRI. Journal of Sex &amp; Marital Therapy2009;35:311‐9. [CENTRAL: CN‐00706808; PUBMED: 19466669] MestonCM . A randomized, placebo‐controlled, crossover study of ephedrine for SSRI‐induced female sexual dysfunction. Journal of Sex &amp; Marital Therapy2004;30:57‐68. ">Meston 2004</a>; <a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>; <a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>; <a href="./references#CD003382-bbs2-0018" title="HensleyPL , NurnbergHG , SlonimskiC , PaineS . Responders and nonresponders to sildenafil citrate therapy for SRI‐FSD. 157th Annual Meeting of the American Psychiatric Association, May 01‐06, 2004, New York, NY. 2004. NurnbergHG , HensleyPL , CroftHA , FavaM , WarnockJK , PaineS . Sildenafil citrate treatment for SRI‐associated female sexual dysfunction. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco, CA. 2003. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , WarnockJK , CroftHA , et al. Sildenafil for selective reuptake inhibitor associated female dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429592] ">Nurnberg 2002</a>; <a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>), and four studies included only men ( <a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>; <a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>). One study did not describe the gender of those participating (<a href="./references#CD003382-bbs2-0013" title="AshtonAK , MasandPS , GuptaS , FrankBL . Bupropion sustained release for SSRI‐induced sexual dysfunction: a randomized, double‐blind, placebo‐controlled, parallel group study. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL2000:NR684. MasandPS , AshtonAK , GuptaS , FrankB . Sustained‐release bupropion for selective serotonin reuptake inhibitor‐induced sexual dysfunction: a randomised, double‐blind, placebo‐controlled, parallel‐group study. American Journal of Psychiatry2001;158:805‐7. [PUBMED: 11329407] ">Masand 2001</a>), and the remaining studies recruited both men and women. </p> <p>The participants in studies had wholly, or partially, recovered from the disorder for which antidepressants had been prescribed ‐ most commonly depression (see <a href="./references#CD003382-sec2-0020" title="">Characteristics of included studies</a>). Two studies reported inclusion of mood and anxiety disorders (<a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>), and one study included participants treated for depression, bipolar disorder and obsessive compulsive disorder (<a href="./references#CD003382-bbs2-0010" title="JacobsenFM , Comas‐DiazL . A double‐blind placebo‐controlled trial of yohimbine for treatment of SRI‐induced sexual dysfunction. 149th Annual Meeting of the American Psychiatric Association. 1996. ">Jacobsen 1996</a>). One study was restricted to people treated for panic disorder (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>). </p> <p>While most studies did not restrict inclusion to particular types of sexual dysfunction, one study employing sildenafil restricted inclusion to antidepressant‐induced erectile dysfunction (<a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>), and another investigating bethanecol limited inclusion to ejaculatory delay or anorgasmia (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>). </p> </section> <section id="CD003382-sec4-0017"> <h5 class="title">Interventions</h5> <p>The range of intervention types assessed was limited and is outlined below.</p> <section id="CD003382-sec5-0001"> <h6 class="title">Addition of further medication</h6> <p>The majority of studies assessed the addition of further medication to ongoing antidepressant treatment using a placebo control. Two studies had more than one active treatment arm in addition to the placebo arm of the trial (<a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>; <a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>). </p> <p>The interventions for which the greatest number of studies were identified were bupropion and sildenafil. </p> <p>Sildenafil, a phosphodiesterase inhibitor, was investigated in five trials with a total of 503 participants (<a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>; <a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0018" title="HensleyPL , NurnbergHG , SlonimskiC , PaineS . Responders and nonresponders to sildenafil citrate therapy for SRI‐FSD. 157th Annual Meeting of the American Psychiatric Association, May 01‐06, 2004, New York, NY. 2004. NurnbergHG , HensleyPL , CroftHA , FavaM , WarnockJK , PaineS . Sildenafil citrate treatment for SRI‐associated female sexual dysfunction. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco, CA. 2003. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , WarnockJK , CroftHA , et al. Sildenafil for selective reuptake inhibitor associated female dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429592] ">Nurnberg 2002</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>; <a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>). The range of doses taken once daily varied between 25 mg and 100 mg in one study (<a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>), and a dose between 50 mg and 100mg was employed in the remaining four studies (<a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0018" title="HensleyPL , NurnbergHG , SlonimskiC , PaineS . Responders and nonresponders to sildenafil citrate therapy for SRI‐FSD. 157th Annual Meeting of the American Psychiatric Association, May 01‐06, 2004, New York, NY. 2004. NurnbergHG , HensleyPL , CroftHA , FavaM , WarnockJK , PaineS . Sildenafil citrate treatment for SRI‐associated female sexual dysfunction. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco, CA. 2003. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , WarnockJK , CroftHA , et al. Sildenafil for selective reuptake inhibitor associated female dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429592] ">Nurnberg 2002</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>; <a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>). </p> <p>Bupropion, which is thought to act by dual noradrenaline and dopamine reuptake inhibition (<a href="./references#CD003382-bbs2-0091" title="Stahl SM ,  PradkoJF ,  HaightBR ,  ModellJG ,  RockettCB ,  Learned‐CoughlinS . A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. The Primary Care Companion to the Journal of Clinical Psychiatry2004;6:159‐66. [PUBMED: 15361919] ">Stahl 2004</a>), was investigated in five trials with a total of 579 participants (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>; <a href="./references#CD003382-bbs2-0004" title="DeBattistaC , SolvasonB , PoirierJ , KendrickE , LoraasE . A placebo‐controlled, randomized, double‐blind study of adjunctive bupropion sustained release in the treatment of SSRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2005;66:844‐8. [PUBMED: 16013899] DeBattistaC , SolvasonHB , FlemingS , KendrickW , SchatzbergA . A placebo‐controlled, double‐blind study of bupropion SR in the treatment of SSRI‐induced sexual dysfunction. 41st Annual NCDEU Meeting. 2001. DeBattistaC , SolvasonHB , SchatzbergAF , KendrickE , LoraasE . A placebo‐controlled, double‐blind study of bupropion sustained release for sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; New Orleans, LA2001:NR531. ">DeBattista 2005</a>; <a href="./references#CD003382-bbs2-0013" title="AshtonAK , MasandPS , GuptaS , FrankBL . Bupropion sustained release for SSRI‐induced sexual dysfunction: a randomized, double‐blind, placebo‐controlled, parallel group study. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL2000:NR684. MasandPS , AshtonAK , GuptaS , FrankB . Sustained‐release bupropion for selective serotonin reuptake inhibitor‐induced sexual dysfunction: a randomised, double‐blind, placebo‐controlled, parallel‐group study. American Journal of Psychiatry2001;158:805‐7. [PUBMED: 11329407] ">Masand 2001</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). Bupropion (sustained release) was prescribed at a dose of 150 mg daily in two studies (<a href="./references#CD003382-bbs2-0004" title="DeBattistaC , SolvasonB , PoirierJ , KendrickE , LoraasE . A placebo‐controlled, randomized, double‐blind study of adjunctive bupropion sustained release in the treatment of SSRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2005;66:844‐8. [PUBMED: 16013899] DeBattistaC , SolvasonHB , FlemingS , KendrickW , SchatzbergA . A placebo‐controlled, double‐blind study of bupropion SR in the treatment of SSRI‐induced sexual dysfunction. 41st Annual NCDEU Meeting. 2001. DeBattistaC , SolvasonHB , SchatzbergAF , KendrickE , LoraasE . A placebo‐controlled, double‐blind study of bupropion sustained release for sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; New Orleans, LA2001:NR531. ">DeBattista 2005</a>; <a href="./references#CD003382-bbs2-0013" title="AshtonAK , MasandPS , GuptaS , FrankBL . Bupropion sustained release for SSRI‐induced sexual dysfunction: a randomized, double‐blind, placebo‐controlled, parallel group study. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL2000:NR684. MasandPS , AshtonAK , GuptaS , FrankB . Sustained‐release bupropion for selective serotonin reuptake inhibitor‐induced sexual dysfunction: a randomised, double‐blind, placebo‐controlled, parallel‐group study. American Journal of Psychiatry2001;158:805‐7. [PUBMED: 11329407] ">Masand 2001</a>), and at 150 mg twice daily in the remaining studies (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). </p> <p>A wide range of other agents were investigated in fewer studies including:</p> <p> <ol id="CD003382-lst1-0001"> <li> <p>A second phosphodiesterase inhibitor, tadalafil (in doses of 10 mg or 20 mg), tested in one study with 54 participants (<a href="./references#CD003382-bbs2-0006" title="EvliyaogluY ,   Yelsel K , KobanerM , AlmaE , SaygiliM . Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology2011;77:1137‐41. [PUBMED: 21316088] ">Evliyaoğlu 2011</a>). </p> </li> <li> <p>Two 5HT1A receptor agonists: VML‐670, a 5‐HT1A receptor agonist (300 μg once daily) tested in a study with 288 participants (<a href="./references#CD003382-bbs2-0001" title="BaldwinD , HutchisonJ , DonaldsonK , ShawB , SmithersA . Selective serotonin re‐uptake inhibitor treatment‐emergent sexual dysfunction: randomized double‐blind placebo‐controlled parallel‐group fixed‐dose study of a potential adjuvant compound, VML‐670. Journal of Psychopharmacology2008;22(1):55‐63. [CENTRAL: CN‐00627684; PUBMED: 17715211] ">Baldwin 2008</a>), and buspirone, another 5‐HT1A receptor agonist (30 mg daily), tested in a study with 61 participants (<a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>); the <a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a> study also included an active treatment as the comparison treatment, amantadine, a dopaminergic agent (50 mg twice daily). </p> </li> <li> <p>A herbal extract of <i>Ginkgo biloba:</i> two studies with 61 participants tested a herbal extract of <i>Ginkgo biloba</i> (240 mg daily) (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>; <a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>). </p> </li> <li> <p>Granisetron, a 5‐HT3 antagonist, was investigated in two studies with 32 participants (<a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>; <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a>). <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a> used a dose of 1 mg to 2 mg, but the dosage was not specified in the other study. </p> </li> <li> <p>Bethanecol (20 mg), an agent with mixed cholinergic and adrenergic effects, investigated in one study with 12 participants (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>). </p> </li> <li> <p>Two 5HT2 receptor antagonists, olanzapine (2.5 mg daily) and mirtazapine (15 mg daily) were investigated in the same four‐arm study (<a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>). This study also included an active treatment comparison with yohimbine, an alpha‐2 adrenoceptor antagonist (5.4 mg daily). Yohimbine was also studied at a dose of 5.4 mg three times daily in a another trial with 33 participants (<a href="./references#CD003382-bbs2-0010" title="JacobsenFM , Comas‐DiazL . A double‐blind placebo‐controlled trial of yohimbine for treatment of SRI‐induced sexual dysfunction. 149th Annual Meeting of the American Psychiatric Association. 1996. ">Jacobsen 1996</a>). </p> </li> <li> <p>Ephedrine was investigated in one study (<a href="./references#CD003382-bbs2-0014" title="AhroldTK , MestonCM . Effects of SNS activation on SSRI‐induced sexual side effects differ by SSRI. Journal of Sex &amp; Marital Therapy2009;35:311‐9. [CENTRAL: CN‐00706808; PUBMED: 19466669] MestonCM . A randomized, placebo‐controlled, crossover study of ephedrine for SSRI‐induced female sexual dysfunction. Journal of Sex &amp; Marital Therapy2004;30:57‐68. ">Meston 2004</a>). </p> </li> <li> <p>Two different doses of maca root extract were compared in one study (<a href="./references#CD003382-bbs2-0005" title="DordingCM , FisherL , PapakostasG , FarabaughA , SonawallaS , FavaM , et al. A double‐blind, randomized, pilot dose‐finding study of maca root (L. meyenii) for the management of SSRI‐Induced sexual dysfunction. CNS Neuroscience &amp; Therapeutics2008;14:182‐91. [CENTRAL: CN‐00665598; DOI: 10.1111/j.1755‐5949.2008.00052.x; PUBMED: 18801111] ">Dording 2008</a>). </p> </li> </ol> </p> </section> <section id="CD003382-sec5-0002"> <h6 class="title">Change in antidepressant prescription</h6> <p>One study assessed changing from an SSRI to an antidepressant, nefazodone, with a different mode of action (<a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>). </p> </section> <section id="CD003382-sec5-0003"> <h6 class="title">Other approaches</h6> <p>No studies were identified that assessed the use of drug holidays, psychological interventions, or mechanical devices to treat sexual dysfunction. </p> </section> </section> <section id="CD003382-sec4-0018"> <h5 class="title">Outcomes</h5> <section id="CD003382-sec5-0004"> <h6 class="title">1) Measures of sexual function, dysfunction and satisfaction</h6> <p>The trials used a variety of outcome measures to assess initial sexual function and response to treatment. These included both self‐assessment and externally‐rated measures. The scales used included: </p> <p> <ol id="CD003382-lst1-0002"> <li> <p>International Index of Erectile Function (IIEF; <a href="./references#CD003382-bbs2-0085" title="RosenRC , RileyA , WagnerG , OsterlohIH , KirkpatrickJ , MishraA . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997;49:822‐30. ">Rosen 1997</a>). </p> </li> <li> <p>Arizona Sexual Experiences Scale (ASEX; <a href="./references#CD003382-bbs2-0080" title="McGahueyCA , GelenbergAJ , LaukesCA , MorenoFA , DelgadoPL , McKnightKM , et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. Journal of Sex &amp; Marital Therapy2000;26:25‐40. ">McGahuey 2000</a>). </p> </li> <li> <p>Changes in Sexual Functioning Questionnaire (CSFQ; <a href="./references#CD003382-bbs2-0062" title="ClaytonAH , McGarveyEL , ClavetGJ . The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacology Bulletin1997;33:731‐45. ">Clayton 1997</a>). </p> </li> <li> <p>Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS; <a href="./references#CD003382-bbs2-0054" title="AlthofSE , CortyEW , LevineSB , LevineF , BurnettAL , McVaryK , et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology1999;53:793‐9. [MEDLINE: 10197859] ">Althof 1999</a>). </p> </li> <li> <p>General Assessment Questions (GAQ; <a href="./references#CD003382-bbs2-0006" title="EvliyaogluY ,   Yelsel K , KobanerM , AlmaE , SaygiliM . Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology2011;77:1137‐41. [PUBMED: 21316088] ">Evliyaoğlu 2011</a>). </p> </li> <li> <p>Sexual Side Effects Scale (SSES; <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a>). </p> </li> <li> <p>Brief Index of Sexual Functioning for Women (BISF‐W; <a href="./references#CD003382-bbs2-0092" title="TaylorJF , RosenRC , LeiblumSR . Self‐report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Archives of Sexual Behavior1994;23:627‐43. [MEDLINE: 7872859] ">Taylor 1994</a>). </p> </li> <li> <p>Feiger Sexual Function and Satisfaction Questionnaire (FSFSQ; <a href="./references#CD003382-bbs2-0066" title="FeigerA , KievA , ShrivastavaRK , WisselinkPG , WilcoxCS . Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. Journal of Clinical Psychiatry1996;57 Suppl 2:53‐62. [MEDLINE: 8626364] ">Feiger 1996</a>). </p> </li> <li> <p>Udvalg fur Kliniske Undersogelser side effect rating scale (UKU; <a href="./references#CD003382-bbs2-0079" title="LingjaerdeO , AhlforsUG , BechF , DenckerSJ , ElgenK . The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients. Acta Psychiatrica Scandinavica Supplementum1987;334:1‐100. ">Lingjaerde 1987</a>). </p> </li> <li> <p>Massachussetts General Hospital‐Sexual Functioning Questionnaire (MGH‐SFQ; <a href="./references#CD003382-bbs2-0078" title="LabbateLA , LareSB . Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. Psychotherapy and Psychosomatics2001;70:221‐5. ">Labbate 2001</a>). </p> </li> <li> <p>Clinical Global Impression Scale adapted for Sexual Function (CGI‐SF; <a href="./references#CD003382-bbs2-0070" title="GuyW . ECDEU assessment manual for psychopharmacology. Washington DC: US Department of Health, Education and Welfare, 1976:534‐7. ">Guy 1976</a>). </p> </li> <li> <p>The Physician's Rating of Sexual Dysfunction Symptoms (PRSDS; <a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>). </p> </li> <li> <p>A modified version of the Rush‐Presbyterian Sexual Function Inventory (R‐SFI; <a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>). </p> </li> <li> <p>Interviewer Rating of Sexual Dysfunction, a semi‐structured interview (<a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>). </p> </li> <li> <p>Visual analogue scales (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>; <a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>). </p> </li> <li> <p>Investigator‐devised measures (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>; <a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>). </p> </li> </ol> </p> </section> <section id="CD003382-sec5-0005"> <h6 class="title">2) Measures of psychiatric symptoms</h6> <p>Depressive symptoms were measured using the Hamilton Rating Scale for Depression (HAM‐D; <a href="./references#CD003382-bbs2-0072" title="HamiltonMA . A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry1960;23:56‐62. ">Hamilton 1960</a>), Clinical Global Impression, and Beck Depression Inventory (<a href="./references#CD003382-bbs2-0059" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives of General Psychiatry1961;4:561‐71. ">Beck 1961</a>). </p> <p>Anxiety symptoms were measured using the Hamilton Rating Scale for Anxiety (HAM‐A; <a href="./references#CD003382-bbs2-0071" title="HamiltonM . The assessment of anxiety states by rating. British Journal of Medical Psychology1959;32:50‐5. ">Hamilton 1959</a>), and the State‐Trait Anxiety Inventory (<a href="./references#CD003382-bbs2-0090" title="SpielbergerCD , GorsuchRL , LusheneR , VaggPR , JacobsGA . Manual for the State‐Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983. ">Spielberger 1983</a>). </p> </section> </section> </section> <section id="CD003382-sec3-0021"> <h4 class="title">Excluded studies</h4> <p>A number of studies were excluded from the review (see <a href="./references#CD003382-sec2-0021" title="">Characteristics of excluded studies</a>). The most common reason for exclusion was that randomised allocation was not employed, or it was not established that the sexual dysfunction was attributable to use of antidepressants. </p> <section id="CD003382-sec4-0019"> <h5 class="title">Ongoing studies</h5> <p>Six studies were identified that are ongoing, or yet to report (see <a href="./references#CD003382-sec2-0023" title="">Characteristics of ongoing studies</a>). It appears, from published trial registers, that one ongoing study is investigating change of antidepressant (<a href="./references#CD003382-bbs2-0051" title="Takeda Global Research &amp; Development Center, Inc . A randomized, double‐blind, parallel‐group, active‐controlled, flexible‐dose study evaluating the effect of Lu AA21004 vs escitalopram on sexual functioning in adults with well‐treated major depressive disorder experiencing selective serotonin reuptake inhibitor‐induced sexual dysfunction. ">Takeda 2011</a>). The remaining studies are investigating trazodone (<a href="./references#CD003382-bbs2-0047" title="Trazodone for SSRI‐sexual dsyfunction (T‐SSRI‐SD). ">Chiang 2010</a>), ropinirole (<a href="./references#CD003382-bbs2-0049" title="Treating sexual dysfunction from selective serotonin reuptake inhibitor (SSRI) medication: a study comparing Requip CR to placebo. ">Hellerstein 2008</a>), maca root (<a href="./references#CD003382-bbs2-0048" title="Study of maca root for the treatment of antidepressant‐induced sexual dysfunction in females (MGH). ">Dording 2010</a>), combinations of testosterone with sildenafil or buspirone (<a href="./references#CD003382-bbs2-0052" title="Lybrido(s) and SSRIs @Home: A double blind, randomized, cross‐over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction in combination with SSRI use. ">Van Rooiji 2010</a>), and <i>Ginkgo biloba</i>, sex therapy, and a combination of the two (<a href="./references#CD003382-bbs2-0050" title="MestonC . Ginkgo biloba: antidepressant‐induced sexual dysfunction. [NCT00034021] MestonCM , RelliniAH , TelchMJ . Short‐ and long‐term effects of Ginkgo biloba extract on sexual dysfunction in women. Archives of Sexual Behavior2008;37:530‐47. [DOI: 10.1007/s10508‐008‐9316‐2; PUBMED: 18274887] ">Meston 2008</a>). </p> </section> <section id="CD003382-sec4-0020"> <h5 class="title">Studies awaiting classification</h5> <p>Four studies are awaiting classification (see <a href="./references#CD003382-sec2-0022" title="">Characteristics of studies awaiting classification</a>), and, if suitable, will be included in future updates of this review. </p> </section> <section id="CD003382-sec4-0021"> <h5 class="title">New studies found at this update</h5> <p>The original version of this review included 15 studies with around 900 participants. The current version includes 23 studies with 1886 participants, so there has been a substantial increase in the availability of data from randomised trials to address this area of interest. </p> </section> </section> </section> <section id="CD003382-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias judgements are presented graphically in <a href="#CD003382-fig-0002">Figure 2</a> and <a href="#CD003382-fig-0003">Figure 3</a> with further details tabulated in the <a href="./references#CD003382-sec2-0020" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD003382-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003382-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003382-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003382-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD003382-sec3-0022"> <h4 class="title">Allocation</h4> <p>There was generally little information provided on methods used for randomisation or used to maintain concealment of allocation. </p> </section> <section id="CD003382-sec3-0023"> <h4 class="title">Blinding</h4> <p>While most studies reported use of blinding, commonly a 'double‐blind' design (<a href="#CD003382-fig-0002">Figure 2</a>), the extent of blinding was well described in a minority of studies. <a href="./references#CD003382-bbs2-0014" title="AhroldTK , MestonCM . Effects of SNS activation on SSRI‐induced sexual side effects differ by SSRI. Journal of Sex &amp; Marital Therapy2009;35:311‐9. [CENTRAL: CN‐00706808; PUBMED: 19466669] MestonCM . A randomized, placebo‐controlled, crossover study of ephedrine for SSRI‐induced female sexual dysfunction. Journal of Sex &amp; Marital Therapy2004;30:57‐68. ">Meston 2004</a> described testing participant blinding for effectiveness, and finding that nine out of 11 women correctly identified the order of treatment received. </p> </section> <section id="CD003382-sec3-0024"> <h4 class="title">Incomplete outcome data</h4> <p>The majority of included studies did not include, or did not report, inclusion of withdrawals or dropouts in analyses. Four of the studies specified that they included withdrawals and dropouts in analyses by carrying forward prior observations (<a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>; <a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). None followed up withdrawals to obtain further outcome data. The data currently available on dropout rates for <a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a> refer to the total over both the initial placebo‐controlled period, and the second stage of the trial in which all participants received sildenafil. </p> </section> <section id="CD003382-sec3-0025"> <h4 class="title">Selective reporting</h4> <p>It was unclear in the majority of studies whether there had been selective reporting of data, since original study protocols were not available. In some cases, only data from particular subscales or questions within a larger scale were reported. </p> </section> </section> <section id="CD003382-sec2-0010"> <h3 class="title" id="CD003382-sec2-0010">Effects of interventions</h3> <p>See: <a href="./full#CD003382-tbl-0001"><b>Summary of findings for the main comparison</b> Sildenafil versus placebo</a>; <a href="./full#CD003382-tbl-0002"><b>Summary of findings 2</b> Bupropion versus placebo</a> </p> <section id="CD003382-sec3-0026"> <h4 class="title">Comparison one: Addition of phosphodiesterase inhibitor</h4> <section id="CD003382-sec4-0022"> <h5 class="title">1.1 Sildenafil versus placebo</h5> <p>Six trials were identified that compared the effect of augmenting antidepressant treatment with sildenafil or placebo. A newer trial in men with erectile dysfunction, <a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>, was added to the two trials included in the original version of this review (<a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). Two trials in women were identified (<a href="./references#CD003382-bbs2-0018" title="HensleyPL , NurnbergHG , SlonimskiC , PaineS . Responders and nonresponders to sildenafil citrate therapy for SRI‐FSD. 157th Annual Meeting of the American Psychiatric Association, May 01‐06, 2004, New York, NY. 2004. NurnbergHG , HensleyPL , CroftHA , FavaM , WarnockJK , PaineS . Sildenafil citrate treatment for SRI‐associated female sexual dysfunction. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco, CA. 2003. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , WarnockJK , CroftHA , et al. Sildenafil for selective reuptake inhibitor associated female dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429592] ">Nurnberg 2002</a>; <a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>), but outcome data were only available from one (<a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>). A 'Summary of findings' table is available (<a href="./full#CD003382-tbl-0001">summary of findings Table for the main comparison</a>). </p> <section id="CD003382-sec5-0006"> <h6 class="title">1.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>For men, ratings of erectile dysfunction showed a benefit of sildenafil over placebo (<a href="#CD003382-fig-0004">Figure 4</a>). Data from two studies found those receiving sildenafil scored better than those receiving placebo on questions from the IIEF regarding ability to achieve erection (MD 1.04, 95% CI 0.65 to 1.44; I<sup>2</sup> = 34%) and maintain erection (MD 1.18, 95% CI 0.78 to 1.59; I<sup>2</sup> = 53%) (<a href="./references#CD003382-fig-00101" title="">Analysis 1.1</a>) (<a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). The remaining study in men found total EDITS scores also favoured sildenafil (MD 21.60, 95% CI 4.30 to 38.90) (<a href="./references#CD003382-fig-00102" title="">Analysis 1.2</a>) (<a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>). The I<sup>2</sup>values reported are consistent with moderate statistical heterogeneity between studies on the IIEF ratings. </p> <div class="figure" id="CD003382-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.1 endpoint International Index of Erectile Function (IIEF) scores" data-id="CD003382-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.1 endpoint International Index of Erectile Function (IIEF) scores </p> </div> </div> </div> <p>For women, ratings of overall sexual dysfunction with the clinician‐rated CGI‐SF favoured sildenafil (MD ‐0.80, 95% CI ‐1.20 to ‐0.40) (<a href="./references#CD003382-fig-00103" title="">Analysis 1.3</a>), but results with the participant‐rated ASEX were consistent with benefits from either sildenafil or placebo (MD ‐0.50, 95% CI ‐2.24 to 1.24) (<a href="./references#CD003382-fig-00105" title="">Analysis 1.5</a>). </p> </section> <section id="CD003382-sec5-0007"> <h6 class="title">1.1.2 Effect on sexual satisfaction and functioning</h6> <p>Similar effects of sildenafil were observed for men (<a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>), and women (<a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>), on the CGI‐SF (RR 0.44, 95% CI 0.33 to 0.58) (<a href="./references#CD003382-fig-00104" title="">Analysis 1.4</a>). ASEX scores from two studies in men favoured sildenafil (MD ‐4.62, 95% CI ‐6.29 to ‐2.95; <a href="#CD003382-fig-0005">Figure 5</a>) (<a href="./references#CD003382-fig-00105" title="">Analysis 1.5</a>) (<a href="./references#CD003382-bbs2-0009" title="GinsbergDL , AdlerL , McCulloughA , YingP , WuK , RotrosenJ . Sildenafil treatment of serotonin‐reuptake inhibitor (SRI)‐induced sexual dysfunction. 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, USA. 2001. GinsbergDL , AdlerLA , McCulloughA , YingP , WuK , RotrosenJP . Sildenafil for SRI‐induced sexual dysfunction: a placebo‐controlled trial. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429593] ">Ginsberg 2001</a>; <a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). This appears to differ from the uncertain effect found for women as noted above. In the study in women from which data are available (<a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>), no difference was observed between sildenafil and placebo in endpoint total scores and subscales of SFQ (<a href="./references#CD003382-fig-00114" title="">Analysis 1.14</a>), and UNM‐SFI (<a href="./references#CD003382-fig-00115" title="">Analysis 1.15</a>). </p> <div class="figure" id="CD003382-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.5 endpoint Arizona Sexual Experience Scale (ASEX) total scores" data-id="CD003382-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.5 endpoint Arizona Sexual Experience Scale (ASEX) total scores </p> </div> </div> </div> <p>In one study sildenafil was associated with improved scores on the MGH‐SFQ for total score and all domains (<a href="./references#CD003382-fig-00107" title="">Analysis 1.7</a>) (<a href="./references#CD003382-bbs2-0019" title="HensleyPL , NurnbergHG , FavaM , GelenbergAJ , LaurielloJ , PaineS . Randomized clinical trial of selective PDE‐5 inhibitor (sildenafil) treatment of SSRI treatment‐emergent erectile dysfunction. 156th Annual Meeting of the American Psychiatric Association. 2003. NumbergHG , HensleyPL , PaineS , SlonimskiC . Effects of sildenafil citrate on ejaculatory delay and erectile dysfunction. 157th Annual Meeting of the American Psychiatric Association; 2004 May 1‐6; New York2004:NR227. NurnbergHG , FavaM , GelenbergAJ , HensleyPL , PaineS . Open‐label sildenafil treatment of partial and non‐responders to double‐blind treatment in men with antidepressant‐associated sexual dysfunction. International Journal of Impotence Research2007;19(2):167‐75. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , SiegelRL . Sildenafil citrate in SSRI antidepressant treatment emergent sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:N44. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sidenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL2000:NR679. NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , HarrisonWM , et al. Sildenafil for SRI‐associated sexual dysfunction: a three‐center, six‐week, double‐blind, placebo‐controlled study in 90 men. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [CN‐00430097] NurnbergHG , GelenbergAJ , FavaM , HensleyPL , LaurielloJ , PaineS . Sildenafil citrate in a double‐blind, placebo‐controlled study with extension for SSRI‐associated sexual dysfunction: open‐label results. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR672. NurnbergHG , HensleyP , LaurielloJ , GelenbergAJ , FavaM . Sildenafil citrate for the treatment of sexual dysfunction associated with serotonergic reuptake inhibitors. 4th Congress of the European Society for Sexual and Impotence Research. Rome, 2001:Poster 104. NurnbergHG , HensleyPL . Maintaining compliance and remission in MDD with sildenafil prescription for SSR‐SD. 156th Annual Meeting of the American Psychiatric Association, May 17‐22, San Francisco CA2003:No. 110. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LauriellaJ , PaineS . Treatment of antidepressant‐associated sexual dysfunction with sildenafil. JAMA: The Journal of the American Medical Association2003;289:56‐64. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , LaurielloJ , PaineS . Nonadrenergic noncholinergic sildenafil treatment of SRI‐associated sexual dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA2002:No. 94. ">Nurnberg 2003</a>). The IIEF, total score, and several subdomains showed benefit from sildenafil (<a href="./references#CD003382-fig-00101" title="">Analysis 1.1</a>), although increased sexual desire was not demonstrated (MD 0.50, 95% CI ‐0.38 to 1.38). In another study (<a href="./references#CD003382-bbs2-0007" title="FavaM , NurnbergGH , SeidmanSN , HollowayW , NicholasS , TsengL , et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant‐associated erectile dysfunction: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry2006;67:240‐6. ">Fava 2006</a>), GEQ responses indicated improvement in erections and ability to have satisfactory sexual intercourse (<a href="./references#CD003382-fig-00112" title="">Analysis 1.12</a>; <a href="./references#CD003382-fig-00113" title="">Analysis 1.13</a>). </p> </section> <section id="CD003382-sec5-0008"> <h6 class="title">1.1.3 Dropout rates</h6> <p>Reported dropout rates were consistent with effects favouring either sildenafil or placebo (RR 0.68, 95% CI 0.41 to 1.14) (<a href="./references#CD003382-fig-00109" title="">Analysis 1.9</a>). </p> </section> <section id="CD003382-sec5-0009"> <h6 class="title">1.1.4 Change in the primary psychiatric condition</h6> <p>From the two trials that provided data, endpoint HAM‐D scores tended to favour sildenafil but could not exclude a benefit of placebo (MD ‐0.94, 95% CI ‐1.94 to 0.07) (<a href="./references#CD003382-fig-00110" title="">Analysis 1.10</a>); a similar pattern was seen when analysed dichotomously for loss of remission from depression (RR 0.33, 95% CI 0.04 to 3.09) (<a href="./references#CD003382-fig-00111" title="">Analysis 1.11</a>). </p> </section> </section> <section id="CD003382-sec4-0023"> <h5 class="title">1.2 Tadalafil versus placebo</h5> <p>One study was identified that compared the effect of treatment with tadalafil or placebo alongside antidepressant medication (<a href="./references#CD003382-bbs2-0006" title="EvliyaogluY ,   Yelsel K , KobanerM , AlmaE , SaygiliM . Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology2011;77:1137‐41. [PUBMED: 21316088] ">Evliyaoğlu 2011</a>). </p> <section id="CD003382-sec5-0010"> <h6 class="title">1.2.1 Effect on severity of the identified sexual dysfunction</h6> <p>Those receiving tadalafil were more likely than those on placebo to report improved erectile function on the GAQ (RR 11.50, 95% CI 3.03 to 43.67) (<a href="./references#CD003382-fig-00201" title="">Analysis 2.1</a>). IIEF data from <a href="./references#CD003382-bbs2-0006" title="EvliyaogluY ,   Yelsel K , KobanerM , AlmaE , SaygiliM . Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology2011;77:1137‐41. [PUBMED: 21316088] ">Evliyaoğlu 2011</a> are not currently available in a suitable form for meta‐analysis, but qualitatively they suggest an effect on this measure for tadalafil compared to placebo. </p> </section> <section id="CD003382-sec5-0011"> <h6 class="title">1.2.2 Effect on sexual satisfaction and functioning</h6> <p>Results from use of the Sexual Encounter Profile (SEP) diary mean that a benefit of placebo could not be excluded (<a href="./references#CD003382-fig-00202" title="">Analysis 2.2</a>), including rates of overall satisfaction (RR 6.00, 95% CI 0.78 to 46.29). </p> </section> <section id="CD003382-sec5-0012"> <h6 class="title">1.2.3 Dropout rates</h6> <p>Overall rates of early discontinuation were consistent with benefits for tadalafil or placebo (RR 0.36, 95% CI 0.04 to 3.24) (<a href="./references#CD003382-fig-00203" title="">Analysis 2.3</a>), as were rates of discontinuation for apparent lack of efficacy (RR 0.36, 95% CI 0.04 to 3.24). No dropouts were attributed to adverse effects in either group. </p> </section> <section id="CD003382-sec5-0013"> <h6 class="title">1.2.4 Change in the primary psychiatric condition</h6> <p>No data were available on changes in the primary psychiatric condition.</p> </section> </section> </section> <section id="CD003382-sec3-0027"> <h4 class="title">Comparison two: Addition of bupropion</h4> <section id="CD003382-sec4-0024"> <h5 class="title">2.1 Bupropion versus placebo</h5> <p>There are now data available from five trials, with 579 participants, comparing the effect of augmenting antidepressant treatment with bupropion or placebo (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>; <a href="./references#CD003382-bbs2-0004" title="DeBattistaC , SolvasonB , PoirierJ , KendrickE , LoraasE . A placebo‐controlled, randomized, double‐blind study of adjunctive bupropion sustained release in the treatment of SSRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2005;66:844‐8. [PUBMED: 16013899] DeBattistaC , SolvasonHB , FlemingS , KendrickW , SchatzbergA . A placebo‐controlled, double‐blind study of bupropion SR in the treatment of SSRI‐induced sexual dysfunction. 41st Annual NCDEU Meeting. 2001. DeBattistaC , SolvasonHB , SchatzbergAF , KendrickE , LoraasE . A placebo‐controlled, double‐blind study of bupropion sustained release for sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; New Orleans, LA2001:NR531. ">DeBattista 2005</a>; <a href="./references#CD003382-bbs2-0013" title="AshtonAK , MasandPS , GuptaS , FrankBL . Bupropion sustained release for SSRI‐induced sexual dysfunction: a randomized, double‐blind, placebo‐controlled, parallel group study. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL2000:NR684. MasandPS , AshtonAK , GuptaS , FrankB . Sustained‐release bupropion for selective serotonin reuptake inhibitor‐induced sexual dysfunction: a randomised, double‐blind, placebo‐controlled, parallel‐group study. American Journal of Psychiatry2001;158:805‐7. [PUBMED: 11329407] ">Masand 2001</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). A 'Summary of findings' table is available (<a href="./full#CD003382-tbl-0002">summary of findings Table 2</a>). </p> <section id="CD003382-sec5-0014"> <h6 class="title">2.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>Endpoint data for the total scores on rating scales used to identify sexual dysfunction were available from three studies (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>), which gave a standardised mean difference (SMD) of 1.60 (95% CI 1.40 to 1.81) favouring bupropion over placebo (<a href="#CD003382-fig-0006">Figure 6</a>) (<a href="./references#CD003382-fig-00301" title="">Analysis 3.1</a>). There was a high level of statistical inconsistency identified in this analysis (I<sup>2</sup> = 86%), which appears to be driven by the contrast between the striking effect sizes reported in two studies (SMD 1.76, 95% CI 1.45 to 2.07; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>: and SMD 1.73, 95% CI 1.41 to 2.05; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>), and a more modest trend in the third (SMD 0.50, 95% CI ‐0.11 to 1.12; <a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>). The reasons for this inconsistency are unclear. </p> <div class="figure" id="CD003382-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison 3: bupropion vs placebo, outcome: 3.1 endpoint scale total scores" data-id="CD003382-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 3: bupropion vs placebo, outcome: 3.1 endpoint scale total scores </p> </div> </div> </div> <p>Response rates from two studies (<a href="./references#CD003382-bbs2-0004" title="DeBattistaC , SolvasonB , PoirierJ , KendrickE , LoraasE . A placebo‐controlled, randomized, double‐blind study of adjunctive bupropion sustained release in the treatment of SSRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2005;66:844‐8. [PUBMED: 16013899] DeBattistaC , SolvasonHB , FlemingS , KendrickW , SchatzbergA . A placebo‐controlled, double‐blind study of bupropion SR in the treatment of SSRI‐induced sexual dysfunction. 41st Annual NCDEU Meeting. 2001. DeBattistaC , SolvasonHB , SchatzbergAF , KendrickE , LoraasE . A placebo‐controlled, double‐blind study of bupropion sustained release for sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; New Orleans, LA2001:NR531. ">DeBattista 2005</a>; <a href="./references#CD003382-bbs2-0013" title="AshtonAK , MasandPS , GuptaS , FrankBL . Bupropion sustained release for SSRI‐induced sexual dysfunction: a randomized, double‐blind, placebo‐controlled, parallel group study. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13‐18, Chicago, IL2000:NR684. MasandPS , AshtonAK , GuptaS , FrankB . Sustained‐release bupropion for selective serotonin reuptake inhibitor‐induced sexual dysfunction: a randomised, double‐blind, placebo‐controlled, parallel‐group study. American Journal of Psychiatry2001;158:805‐7. [PUBMED: 11329407] ">Masand 2001</a>), defined as 50% reduction in ASEX score, were consistent with greater effects of either bupropion or placebo (RR 0.62, 95% CI 0.09 to 4.41; <a href="#CD003382-fig-0007">Figure 7</a>) (<a href="./references#CD003382-fig-00302" title="">Analysis 3.2</a>), while one study found that women taking bupropion were more likely to achieve a two‐point reduction on CGI‐SF scores than those taking placebo (RR 186.73, 95% CI 11.74 to 2969.23) (<a href="./references#CD003382-fig-00302" title="">Analysis 3.2</a>) (<a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). </p> <div class="figure" id="CD003382-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison 3: bupropion vs placebo, outcome: 3.2 response (as defined by study)" data-id="CD003382-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 3: bupropion vs placebo, outcome: 3.2 response (as defined by study) </p> </div> </div> </div> </section> <section id="CD003382-sec5-0015"> <h6 class="title">2.1.2 Effect on sexual satisfaction and functioning</h6> <p>Endpoint CGI‐SF scores from two studies favoured bupropion (MD ‐1.74, 95% CI ‐1.87 to ‐1.61) (<a href="./references#CD003382-fig-00308" title="">Analysis 3.8</a>) (<a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>; <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). For men taking part in <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>, total scores and all subscales from IIEF, ASEX, and EDITS scales favoured bupropion over placebo (IIEF <a href="./references#CD003382-fig-00303" title="">Analysis 3.3</a>; ASEX <a href="./references#CD003382-fig-00309" title="">Analysis 3.9</a>; EDITS <a href="./references#CD003382-fig-00310" title="">Analysis 3.10</a>; <a href="./references#CD003382-fig-00311" title="">Analysis 3.11</a>). For women taking part in <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>, FSFI total score and subscales other than pain favoured bupropion (<a href="./references#CD003382-fig-00304" title="">Analysis 3.4</a>). </p> <p>In <a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a> CSFQ total scores were consistent with a greater effect of either bupropion or placebo (MD 4.50, 95% CI ‐0.89 to 9.89) (<a href="./references#CD003382-fig-00305" title="">Analysis 3.5</a>), as were subscales other than desire/frequency, where a benefit of bupropion was observed (MD 0.88, 95% CI 0.21 to 1.55). </p> </section> <section id="CD003382-sec5-0016"> <h6 class="title">2.1.3 Dropout rates</h6> <p>There was no statistically significant difference in dropout rates between bupropion and placebo (RR 1.08, 95% CI 0.67 to 1.72) (<a href="./references#CD003382-fig-00306" title="">Analysis 3.6</a>). </p> </section> <section id="CD003382-sec5-0017"> <h6 class="title">2.1.4 Change in the primary psychiatric condition</h6> <p>One trial reported endpoint HAM‐D scores (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>), and found no significant difference between the groups (MD ‐0.60, 95% CI ‐2.62 to 1.42) (<a href="./references#CD003382-fig-00307" title="">Analysis 3.7</a>). </p> </section> </section> </section> <section id="CD003382-sec3-0028"> <h4 class="title">Comparison three: Change of antidepressant</h4> <section id="CD003382-sec4-0025"> <h5 class="title">3.1 Nefazodone versus sertraline</h5> <p>One trial compared the effect of changing antidepressant to nefazodone with effect of restarting sertraline after a two‐week washout period in which sertraline‐induced sexual dysfunction had resolved (<a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>). </p> <section id="CD003382-sec5-0018"> <h6 class="title">3.1.2 Effect on severity of the identified sexual dysfunction</h6> <p>On a physician‐rated measure (PRSDS), sexual dysfunction was significantly less likely to re‐emerge on treatment with nefazodone compared with restarting sertraline (RR 0.34, 95% CI 0.19 to 0.60) (<a href="./references#CD003382-fig-00401" title="">Analysis 4.1</a>). This means the number needed to treat for an additional beneficial outcome (NNTB) with nefazodone, that is for one additional person to avoid re‐emergence of sexual dysfunction, was two (95% CI 2 to 4). This benefit of using nefazodone was seen by the end of the first week of treatment (<a href="./references#CD003382-fig-00401" title="">Analysis 4.1</a>). </p> </section> <section id="CD003382-sec5-0019"> <h6 class="title">3.1.2 Effect on sexual satisfaction and functioning</h6> <p>Differences in participant‐rated overall sexual satisfaction did not achieve statistical significance (MD 17.22, 95% CI ‐4.57 to 39.01) (<a href="./references#CD003382-fig-00402" title="">Analysis 4.2</a>). </p> </section> <section id="CD003382-sec5-0020"> <h6 class="title">3.1.3 Dropout rates</h6> <p>No significant difference was noted between groups in overall dropout rates, RR 0.83 (95% CI 0.43 to 1.60) nor in dropouts attributed to adverse effects, RR 0.46 (95% CI 0.17 to 1.25). </p> </section> <section id="CD003382-sec5-0021"> <h6 class="title">3.1.4 Change in the primary psychiatric condition</h6> <p>There was no significant difference in HAM‐D between the two groups at the end of the trial (MD ‐1.57, 95% CI ‐4.51 to 1.37). </p> </section> </section> </section> <section id="CD003382-sec3-0029"> <h4 class="title">Comparison four: Addition of Ginkgo biloba</h4> <section id="CD003382-sec4-0026"> <h5 class="title">4.1 <i>Ginkgo biloba</i> versus placebo </h5> <p>Two studies compared the effect of augmenting antidepressant treatment with <i>Ginkgo biloba</i> or placebo (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>; <a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>). </p> <section id="CD003382-sec5-0022"> <h6 class="title">4.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>There was no significant difference in endpoint sexual dysfunction between the groups on most questions of a nine‐item questionnaire in one study (<a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>) . On the 'satisfaction to orgasm' question, scores were better in the placebo arm (MD ‐1.12, 95% CI ‐2.00 to ‐0.24). Only data from the five items assessed in both genders was provided in sufficient detail for analysis. </p> <p>In the second study (<a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>), total scores on an investigator‐developed scale of sexual dysfunction were compatible with a benefit of either placebo or <i>Ginkgo biloba</i> (MD 3.80, 95% CI ‐1.94 to 9.54) (<a href="./references#CD003382-fig-00502" title="">Analysis 5.2</a>). </p> </section> <section id="CD003382-sec5-0023"> <h6 class="title">4.1.2 Effect on sexual satisfaction and functioning</h6> <p>No other data on sexual satisfaction or functioning were reported.</p> </section> <section id="CD003382-sec5-0024"> <h6 class="title">4.1.3 Dropout rates</h6> <p>There was no significant difference in the rate of dropouts between the two arms of <a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a> (RR 1.33, 95% CI 0.51 to 3.43) (<a href="./references#CD003382-fig-00503" title="">Analysis 5.3</a>). There was an overall dropout rate of 22% in <a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>, but the distribution of dropouts between treatment arms was unclear. </p> </section> <section id="CD003382-sec5-0025"> <h6 class="title">4.1.4 Change in the primary psychiatric condition</h6> <p>No data were available on changes in the primary psychiatric condition from <a href="./references#CD003382-bbs2-0012" title="KangBJ , LeeSJ , KimMD , ChoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. Human Psychopharmacology2002;17:279‐84. [MEDLINE: 12404672] KangBJ , LeeSJ , KimMD , JoMJ . A placebo‐controlled, double‐blind trial of Ginkgo biloba for antidepressant‐induced sexual dysfunction. European Neuropsychopharmacology2002;12(Suppl 3):S177. [DOI: http://dx.doi.org/10.1016/S0924‐977X(02)80137‐7] ">Kang 2002</a>. Ratings of depression and anxiety symptoms were obtained by <a href="./references#CD003382-bbs2-0023" title="WheatleyD . Triple‐blind, placebo‐controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human Psychopharmacology2004;19(8):545‐8. ">Wheatley 2004</a>, but sufficient details are not available for analysis here. </p> </section> </section> </section> <section id="CD003382-sec3-0030"> <h4 class="title">Comparison five: Addition of granisetron</h4> <section id="CD003382-sec4-0027"> <h5 class="title">5.1 Granisetron versus placebo</h5> <p>Two trials compared augmentation of antidepressant treatment with granisetron to the addition of placebo (<a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>; <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a>). Data from <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a> were derived from both cross‐over periods of the trial. </p> <section id="CD003382-sec5-0026"> <h6 class="title">5.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>In the <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a> trial both groups had similar change from baseline on SSES scores (MD 0.10, 95% CI ‐2.22 to 2.42). In the <a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a> trial, total scores on both ASEX and FSFSQ were consistent with greater benefit from either granisetron or placebo (ASEX MD 7.90, 95% CI ‐1.87 to 17.67: FSFSQ MD 1.60, 95% CI ‐5.46 to 8.66). </p> </section> <section id="CD003382-sec5-0027"> <h6 class="title">5.1.2 Effect on sexual satisfaction and functioning</h6> <p>In <a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a>, most item scores on both ASEX and FSFSQ were consistent with greater benefit from either granisetron or placebo (<a href="./references#CD003382-fig-00602" title="">Analysis 6.2</a>; <a href="./references#CD003382-fig-00603" title="">Analysis 6.3</a>). Where items did favour one agent, placebo performed better than granisetron (FSFSQ items 1 and 2; and ASEX orgasm satisfaction). </p> </section> <section id="CD003382-sec5-0028"> <h6 class="title">5.1.3 Dropout rates</h6> <p>There was no statistically significant difference in dropout rates between the two groups in the <a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a> trial (RR 6.67, 95% CI 0.39 to 114.78) (<a href="./references#CD003382-fig-00604" title="">Analysis 6.4</a>). There was an overall dropout rate of 35% in <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a>, but the distribution of the dropouts between treatments was not clear. </p> </section> <section id="CD003382-sec5-0029"> <h6 class="title">5.1.4 Change in the primary psychiatric condition</h6> <p>Rates of recurrence of mood symptoms were consistent with benefit of either agent in the <a href="./references#CD003382-bbs2-0017" title="NelsonEB , ShahVN , WelgeJA , KeckPE . A placebo‐controlled, crossover trial of granisetron in SRI‐induced sexual dysfunction. Journal of Clinical Psychiatry2001;62:469‐73. ">Nelson 2001</a> study (RR 2.87, 95%CI 0.12 to 66.75) (<a href="./references#CD003382-fig-00605" title="">Analysis 6.5</a>). In the <a href="./references#CD003382-bbs2-0011" title="JespersenS , BerkM , VanWykC , DeanO , DoddS , SzaboCP , et al. A pilot randomized, double‐blind, placebo‐controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. International Clinical Psychopharmacology2004;19:161‐4. [MEDLINE: 15107659] ">Jespersen 2004</a> study it was reported that CGI for depressive symptoms did not differ between groups, but insufficient details were available for analysis. </p> </section> </section> </section> <section id="CD003382-sec3-0031"> <h4 class="title">Comparison six: Addition of a 5HT1A receptor agonist</h4> <section id="CD003382-sec4-0028"> <h5 class="title">6.1 VML‐670 versus placebo</h5> <p>Only the <a href="./references#CD003382-bbs2-0001" title="BaldwinD , HutchisonJ , DonaldsonK , ShawB , SmithersA . Selective serotonin re‐uptake inhibitor treatment‐emergent sexual dysfunction: randomized double‐blind placebo‐controlled parallel‐group fixed‐dose study of a potential adjuvant compound, VML‐670. Journal of Psychopharmacology2008;22(1):55‐63. [CENTRAL: CN‐00627684; PUBMED: 17715211] ">Baldwin 2008</a> study compared augmentation of antidepressant treatment with VML‐670 to the addition of placebo. </p> <section id="CD003382-sec5-0030"> <h6 class="title">6.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>By the end of the trial, rates of absence of sexual dysfunction, defined by ASEX, were consistent with benefits of either VML‐607 or placebo (RR 1.24, 95% CI 0.86 to 1.77) (<a href="./references#CD003382-fig-00701" title="">Analysis 7.1</a>), as were rates of improvement defined by CGI (RR 1.24, 95% CI 0.71 to 2.17) (<a href="./references#CD003382-fig-00702" title="">Analysis 7.2</a>). </p> </section> <section id="CD003382-sec5-0031"> <h6 class="title">6.1.2 Effect on sexual satisfaction and functioning</h6> <p>ASEX total scores were not presented with sufficient detail for analysis in this review. Items of the ASEX were mostly consistent with benefits of either VML‐607 or placebo (<a href="./references#CD003382-fig-00703" title="">Analysis 7.3</a>), with the exception that men randomised to VML‐670 reported a greater improvement in erectile function (MD ‐0.40, 95% CI ‐0.80 to 0.00). </p> </section> <section id="CD003382-sec5-0032"> <h6 class="title">6.1.3 Dropout rates</h6> <p>No significant difference was noted between groups in overall dropout rates (RR 0.97, 95% CI 0.56 to 1.68), or in dropouts attributed to adverse effects (RR 2.32, 95% CI 0.75 to 7.21) (<a href="./references#CD003382-fig-00704" title="">Analysis 7.4</a>). </p> </section> <section id="CD003382-sec5-0033"> <h6 class="title">6.1.4 Change in the primary psychiatric condition</h6> <p>Insufficient details on HAM‐D scores were available for analysis in this review.</p> </section> </section> <section id="CD003382-sec4-0029"> <h5 class="title">6.2 Buspirone versus placebo</h5> <p>One trial compared the effect in women of augmenting antidepressant treatment with buspirone or placebo (<a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>). </p> <section id="CD003382-sec5-0034"> <h6 class="title">6.2.1 Effect on severity of the identified sexual dysfunction</h6> <p>Sexual dysfunction was identified for study inclusion by clinician‐rated global impression, but insufficient details of the results were presented to allow for analysis in this review. </p> </section> <section id="CD003382-sec5-0035"> <h6 class="title">6.2.2 Effect on sexual satisfaction and functioning</h6> <p>Changes in ratings on visual analogue scales of aspects of sexual functioning were consistent with benefits for either buspirone or placebo (<a href="./references#CD003382-fig-00801" title="">Analysis 8.1</a>), as was change in a summary measure of overall functioning (MD 3.10, 95% CI ‐38.33 to 44.53). </p> </section> <section id="CD003382-sec5-0036"> <h6 class="title">6.2.3 Dropout rates</h6> <p>No significant difference was noted between groups in overall dropout rates (RR 2.00, 95% CI 0.20 to 20.41) (<a href="./references#CD003382-fig-00802" title="">Analysis 8.2</a>) </p> </section> <section id="CD003382-sec5-0037"> <h6 class="title">6.2.4 Change in the primary psychiatric condition</h6> <p>Visual analogue scale ratings of mood (MD 0.80, 95% CI ‐7.61 to 9.21) and energy (MD 5.30, 95% CI ‐3.88 to 14.48) (<a href="./references#CD003382-fig-00801" title="">Analysis 8.1</a>) were consistent with benefits for either buspirone or placebo. Insufficient details on specific depression and anxiety rating scale scores were presented to permit analysis in this review. </p> </section> </section> </section> <section id="CD003382-sec3-0032"> <h4 class="title">Comparison seven: Addition of bethanecol</h4> <section id="CD003382-sec4-0030"> <h5 class="title">7.1 Bethanecol versus placebo</h5> <p>One study compared augmentation of antidepressant treatment with bethanecol against augmentation with placebo (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>). </p> <section id="CD003382-sec5-0038"> <h6 class="title">7.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>Those receiving bethanecol reported higher scores than those receiving placebo on a six‐point visual analogue scale of orgasmic function (MD 3.40, 95% CI 0.99 to 5.81) (<a href="./references#CD003382-fig-00901" title="">Analysis 9.1</a>). </p> </section> <section id="CD003382-sec5-0039"> <h6 class="title">7.1.2 Effect on sexual satisfaction and functioning</h6> <p>Data on erectile function were obtained, but not reported.</p> </section> <section id="CD003382-sec5-0040"> <h6 class="title">7.1.3 Dropout rates</h6> <p>Two of the 12 participants dropped out during the study, but it was unclear from which treatment group(s). </p> </section> <section id="CD003382-sec5-0041"> <h6 class="title">7.1.4 Change in the primary psychiatric condition</h6> <p>One participant (1/12) developed a depressive episode during the study, but it was unclear which treatment s/he was receiving at the time. </p> </section> </section> </section> <section id="CD003382-sec3-0033"> <h4 class="title">Comparison eight: Addition of a 5HT2 receptor antagonist</h4> <p>One trial compared augmentation of antidepressant treatment in women with agents including placebo and two 5HT2 receptor antagonists, olanzapine and mirtazapine (<a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>). These comparisons against placebo are considered separately below: </p> <section id="CD003382-sec4-0031"> <h5 class="title">8.1 Olanzapine versus placebo</h5> <section id="CD003382-sec5-0042"> <h6 class="title">8.1.1 Effect on severity of the identified sexual dysfunction</h6> <p>The group receiving olanzapine reported a greater improvement on a scale of overall sexual satisfaction completed at interview (MD ‐0.70, 95% CI ‐1.17 to ‐0.23). Other measures of sexual function completed at the same time were consistent with benefits for either olanzapine or placebo (<a href="./references#CD003382-fig-01001" title="">Analysis 10.1</a>). </p> </section> <section id="CD003382-sec5-0043"> <h6 class="title">8.1.2 Effect on sexual satisfaction and functioning</h6> <p>Diary ratings were all consistent with benefits for either olanzapine or placebo (<a href="./references#CD003382-fig-01002" title="">Analysis 10.2</a>). </p> </section> <section id="CD003382-sec5-0044"> <h6 class="title">8.1.3 Dropout rates</h6> <p>There was an overall dropout rate of 27%, but the distribution of dropouts between treatment group(s) was unclear. Dropouts attributed to adverse effects were consistent with benefits for either olanzapine or placebo (RR 3.59, 95% CI 0.80 to 16.21) (<a href="./references#CD003382-fig-01003" title="">Analysis 10.3</a>). </p> </section> <section id="CD003382-sec5-0045"> <h6 class="title">8.1.4. Change in the primary psychiatric condition</h6> <p>Change in mood did not differ between groups on diary ratings (MD 0.10, 95% CI ‐0.41 to 0.61) (<a href="./references#CD003382-fig-01002" title="">Analysis 10.2</a>). HAM‐D scores were collected, but insufficient details were provided to allow for analysis. </p> </section> </section> <section id="CD003382-sec4-0032"> <h5 class="title">8.2 Mirtazapine versus placebo</h5> <section id="CD003382-sec5-0046"> <h6 class="title">8.2.1 Effect on severity of the identified sexual dysfunction</h6> <p>Participant ratings of sexual function completed at interview were consistent with benefits for either mirtazapine or placebo (<a href="./references#CD003382-fig-01101" title="">Analysis 11.1</a>), including overall sexual satisfaction (MD 0.10, 95% CI ‐0.29 to 0.49). </p> </section> <section id="CD003382-sec5-0047"> <h6 class="title">8.2.2 Effect on sexual satisfaction and functioning</h6> <p>Diary ratings of overall sexual function were consistent with benefits for either mirtazapine or placebo (MD ‐1.30, ‐5.71 to 3.11), as were other diary ratings of sexual function (<a href="./references#CD003382-fig-01102" title="">Analysis 11.2</a>). </p> <p>Kinsey Structured Interview ratings of sexual satisfaction were better in those receiving placebo than mirtazapine (MD 0.60, 95% CI 0.19 to 1.01) (<a href="./references#CD003382-fig-01103" title="">Analysis 11.3</a>). </p> </section> <section id="CD003382-sec5-0048"> <h6 class="title">8.2.3 Dropout rates</h6> <p>There was an overall dropout rate of 27%, but the distribution of the dropouts between treatments was unclear. More participants dropped out of the mirtazapine group than the placebo group because of adverse effects (RR 6.50, 95% CI 1.56 to 27.07) (<a href="./references#CD003382-fig-01104" title="">Analysis 11.4</a>). </p> </section> <section id="CD003382-sec5-0049"> <h6 class="title">8.2.4 Change in the primary psychiatric condition</h6> <p>Change in mood did not differ between groups on diary ratings (MD ‐0.40, 95% CI ‐0.93 to 0.13). Changes in ratings of energy were better in those receiving mirtazapine (MD ‐0.70, 95% CI ‐1.38 to ‐0.02) (<a href="./references#CD003382-fig-01102" title="">Analysis 11.2</a>). HAM‐D scores were collected, but insufficient details were provided to allow for analysis. </p> </section> </section> <section id="CD003382-sec4-0033"> <h5 class="title">Comparison nine: Yohimbine versus placebo</h5> <p>One trial compared augmentation of antidepressant treatment in women with yohimbine or placebo (<a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>), and provided outcome data for this review. A second study has also been performed (<a href="./references#CD003382-bbs2-0010" title="JacobsenFM , Comas‐DiazL . A double‐blind placebo‐controlled trial of yohimbine for treatment of SRI‐induced sexual dysfunction. 149th Annual Meeting of the American Psychiatric Association. 1996. ">Jacobsen 1996</a>), but data were not available in a form suitable for analysis in this review. </p> <section id="CD003382-sec5-0050"> <h6 class="title">9.1. Effect on severity of the identified sexual dysfunction</h6> <p>Participant ratings of sexual function completed at interview were consistent with benefits for either yohimbine or placebo (<a href="./references#CD003382-fig-01201" title="">Analysis 12.1</a>), including overall sexual satisfaction (MD ‐0.30, 95% CI ‐0.79 to 0.19). </p> </section> <section id="CD003382-sec5-0051"> <h6 class="title">9.2. Effect on sexual satisfaction and functioning</h6> <p>Diary ratings of overall sexual function were consistent with benefits for either yohimbine or placebo (MD 1.20, 95% CI ‐3.24 to 5.64), as were other diary ratings of sexual function (<a href="./references#CD003382-fig-01202" title="">Analysis 12.2</a>). </p> </section> <section id="CD003382-sec5-0052"> <h6 class="title">9.3. Dropout rates</h6> <p>There was an overall dropout rate of 27%, but the distribution of dropouts between treatment group(s) was unclear. Dropouts attributed to adverse effects were consistent with benefits for either yohimbine or placebo (RR 2.23, 95% CI 0.43 to 11.43) (<a href="./references#CD003382-fig-01203" title="">Analysis 12.3</a>). </p> </section> <section id="CD003382-sec5-0053"> <h6 class="title">9.4. Change in the primary psychiatric condition</h6> <p>Change in mood did not differ between groups on diary ratings (MD 0.10, 95% CI ‐0.41 to 0.61) (<a href="./references#CD003382-fig-01202" title="">Analysis 12.2</a>). HAM‐D scores were collected, but insufficient details were provided to allow for analysis. </p> </section> </section> <section id="CD003382-sec4-0034"> <h5 class="title">Comparison ten: Amantadine versus placebo</h5> <p>One trial compared augmentation of antidepressant treatment in women with amantadine or placebo (<a href="./references#CD003382-bbs2-0015" title="MichelsonD , BancroftJ , TargumS , KimY , TepnerR . Female sexual dysfunction associated with antidepressant administration: a randomized, placebo‐controlled study of pharmacologic intervention. American Journal of Psychiatry2000;157:239‐43. MichelsonD , BancroftJ , TargumS , TepnerR , KimY . Female sexual dysfunction associated with antidepressant administration: A randomised, placebo‐controlled study of pharmacologic intervention. XI World Congress of Psychiatry; 1999 Aug 6‐11; Hamburg, Germany1999;II:252. ">Michelson 2000</a>). </p> <section id="CD003382-sec5-0054"> <h6 class="title">10.1. Effect on severity of the identified sexual dysfunction</h6> <p>Sexual dysfunction was identified for study inclusion by clinician‐rated global impression, but insufficient details of the results were presented to allow for analysis here. </p> </section> <section id="CD003382-sec5-0055"> <h6 class="title">10.2. Effect on sexual satisfaction and functioning</h6> <p>Changes in ratings on visual analogue scales of aspects of sexual functioning were consistent with benefits for either amantadine and placebo (<a href="./references#CD003382-fig-01301" title="">Analysis 13.1</a>). </p> </section> <section id="CD003382-sec5-0056"> <h6 class="title">10.3. Dropout rates</h6> <p>No significant difference was noted between groups in overall dropout rates (RR 1.11, 95% CI 0.07 to 16.47) (<a href="./references#CD003382-fig-01302" title="">Analysis 13.2</a>). </p> </section> <section id="CD003382-sec5-0057"> <h6 class="title">10.4. Change in the primary psychiatric condition</h6> <p>Participants randomised to amantadine reported a greater increase in ratings of both mood (MD 8.10, 95% CI 1.23 to 14.97) and energy (MD 12.70, 95% CI 5.30 to 20.10) (<a href="./references#CD003382-fig-01301" title="">Analysis 13.1</a>). Insufficient details on specific depression and anxiety rating scale scores were presented to allow for analysis here. </p> </section> </section> <section id="CD003382-sec4-0035"> <h5 class="title">Comparison eleven: Ephedrine versus placebo</h5> <p>One trial compared the effect of augmenting antidepressant treatment with ephedrine or placebo (<a href="./references#CD003382-bbs2-0014" title="AhroldTK , MestonCM . Effects of SNS activation on SSRI‐induced sexual side effects differ by SSRI. Journal of Sex &amp; Marital Therapy2009;35:311‐9. [CENTRAL: CN‐00706808; PUBMED: 19466669] MestonCM . A randomized, placebo‐controlled, crossover study of ephedrine for SSRI‐induced female sexual dysfunction. Journal of Sex &amp; Marital Therapy2004;30:57‐68. ">Meston 2004</a>). Data were derived from both cross‐over periods of the trial. </p> <section id="CD003382-sec5-0058"> <h6 class="title">11.1. Effect on severity of the identified sexual dysfunction</h6> <p>Ratings at the end of treatment on the BISF‐W were consistent with benefits from either ephedrine or placebo (<a href="./references#CD003382-fig-01401" title="">Analysis 14.1</a>). </p> </section> <section id="CD003382-sec5-0059"> <h6 class="title">11.2. Effect on sexual satisfaction and functioning</h6> <p>No measures to assess sexual satisfaction and functioning were employed in this trial.</p> </section> <section id="CD003382-sec5-0060"> <h6 class="title">11.3. Dropout rates</h6> <p>There was an overall dropout rate of 34%, but the distribution of dropouts between treatment group(s) was unclear. </p> </section> <section id="CD003382-sec5-0061"> <h6 class="title">11.4. Change in the primary psychiatric condition</h6> <p>Ratings of depression were made, but insufficient details were presented to allow for analysis here. </p> </section> </section> <section id="CD003382-sec4-0036"> <h5 class="title">Comparison twelve: Maca root low dose (1.5 g) versus maca root high dose (3 g)</h5> <p>One study was identified that assessed the effects of two different doses of maca root on antidepressant‐induced sexual dysfunction (<a href="./references#CD003382-bbs2-0005" title="DordingCM , FisherL , PapakostasG , FarabaughA , SonawallaS , FavaM , et al. A double‐blind, randomized, pilot dose‐finding study of maca root (L. meyenii) for the management of SSRI‐Induced sexual dysfunction. CNS Neuroscience &amp; Therapeutics2008;14:182‐91. [CENTRAL: CN‐00665598; DOI: 10.1111/j.1755‐5949.2008.00052.x; PUBMED: 18801111] ">Dording 2008</a>). </p> <section id="CD003382-sec5-0062"> <h6 class="title">12.1. Effect on severity of the identified sexual dysfunction</h6> <p>Participants randomised to either dose of maca root reported similar endpoint ratings by ASEX total score (MD ‐0.80, 95% CI ‐6.49 to 4.89) (<a href="./references#CD003382-fig-01501" title="">Analysis 15.1</a>) and MGH‐SFQ total score (MD ‐2.00, 95% CI ‐7.69 to 3.69) (<a href="./references#CD003382-fig-01502" title="">Analysis 15.2</a>). </p> </section> <section id="CD003382-sec5-0063"> <h6 class="title">12.2. Effect on sexual satisfaction and functioning</h6> <p>Similarly, ratings of sexual desire items from both ASEX (MD 0.30, 95% CI ‐1.38 to 1.98) (<a href="./references#CD003382-fig-01501" title="">Analysis 15.1</a>) and MGH‐SFQ (MD ‐0.10, 95% CI ‐1.62 to 1.42) (<a href="./references#CD003382-fig-01502" title="">Analysis 15.2</a>) were similar between groups. </p> </section> <section id="CD003382-sec5-0064"> <h6 class="title">12.3. Dropout rates</h6> <p>Rates of overall dropout did not differ between groups (RR 1.50, 95% CI 0.60 to 3.74) (<a href="./references#CD003382-fig-01503" title="">Analysis 15.3</a>). </p> </section> <section id="CD003382-sec5-0065"> <h6 class="title">12.4. Change in the primary psychiatric condition</h6> <p>The HAM‐D total endpoint score was not significantly different between the groups (MD ‐2.50, 95% CI ‐7.98 to 2.98) nor was the HAM‐A total endpoint score (MD ‐0.40, 95% CI ‐3.15 to 2.35) (<a href="./references#CD003382-fig-01504" title="">Analysis 15.4</a>). </p> </section> </section> </section> <section id="CD003382-sec3-0034"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>Due to the small number of studies in each comparison we were unable to conduct the planned subgroup and sensitivity analyses. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003382-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003382-sec1-0006"></div> <section id="CD003382-sec2-0011"> <h3 class="title" id="CD003382-sec2-0011">Summary of main results</h3> <p>Twenty‐three trials involving 1886 people met the inclusion criteria for the updated review. The original version of this review included 15 studies with around 900 participants randomised, so there has been a substantial increase in the data available from randomised trials to address this area of interest. This update has included both increased data for previously identified strategies (addition of sildenafil or bupropion) and trials of new agents for this indication. All except one trial (<a href="./references#CD003382-bbs2-0008" title="FergusonJM , ShrivastavaRK , StahlSM , HartfordJT , BorianF , IeniJ , et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double‐blind comparison of nefazodone and sertraline. Journal of Clinical Psychiatry2001;62:24‐9. ">Ferguson 2001</a>) assessed the addition of further medication to treat the sexual dysfunction. </p> <p>We were unable to do the intended subgroup analyses by gender, but these are summarised descriptively here to facilitate interpretation. </p> <section id="CD003382-sec3-0035"> <h4 class="title">Men</h4> <p>In men, data for the phosphodiesterase inhibitors sildenafil (three studies, 255 participants; see <a href="./full#CD003382-tbl-0001">summary of findings Table for the main comparison</a>) and tadalafil (one study, 54 participants) indicated that they led to a greater improvement in erectile function than placebo. The estimates of treatment effect observed are similar to those reported for their use in erectile dysfunction due to other causes (<a href="./references#CD003382-bbs2-0067" title="FinkHA , MacDonaldR , RutksIR , NelsonDB , WiltTJ . Sildenafil for male erectile dysfunction: a systematic review and meta‐analysis. Archives of Internal Medicine2002;24:1349‐60. [MEDLINE: 12076233] ">Fink 2002</a>; <a href="./references#CD003382-bbs2-0061" title="CarsonCC , RajferJ , EardleyI , CarrierS , DenneJS , WalkerDJ , et al. The efficacy and safety of tadalafil: an update. BJU International2004;93:1276‐81. [MEDLINE: 15180622] ">Carson 2004</a>). </p> <p>In men, addition of higher dose bupropion has also shown benefit (see <a href="./full#CD003382-tbl-0002">summary of findings Table 2</a>), but this is primarily shown in a single study (234 participants; <a href="./references#CD003382-bbs2-0021" title="SafarinejadMR . The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study. BJU International2010;106:840‐7. [PUBMED: 20067456 ] ">Safarinejad 2010</a>). Replication of this effect is likely to increase confidence in this finding. The magnitude of effect seen on total IIEF score (MD 20.10, 95% CI 17.14 to 23.06) (<a href="./references#CD003382-fig-00303" title="">Analysis 3.3</a>) was similar to that seen in studies of sildenafil (MD 19.36, 95% CI 15.00 to 23.72) (<a href="./references#CD003382-fig-00101" title="">Analysis 1.1</a>). </p> <p>There are also some promising data from a small cross‐over trial of bethanecol suggesting benefit for men with antidepressant‐induced ejaculatory delay or anorgasmia rather than erectile dysfunction (<a href="./references#CD003382-bbs2-0002" title="BernikM , VieiraAHG , NunesPV . Bethanecol chloride for treatment of chlomipramine‐induced orgasmic dysfunction in males [O uso do cloridrato de betanecol no tratamento da disfunção orgásmica induzida pela clomipramina em pacientes do sexo masculino]. Revista do Hospital das Clínicas2004;59(6):357‐60. ">Bernik 2004</a>). Replication in further studies is likely to be necessary for clinicians and patients to have confidence in this effect. </p> </section> <section id="CD003382-sec3-0036"> <h4 class="title">Women</h4> <p>For women it remains uncertain whether sildenafil is more effective than placebo, but outcome data are only available from one study (<a href="./references#CD003382-bbs2-0020" title="NurnbergHG , HensleyPL , HeimanJR , CroftHA , DebattistaC , PaineS . Sildenafil treatment of women with antidepressant ‐ associated sexual dysfunction: a randomized controlled trial. JAMA: The Journal of the American Medical Association2008;300(4):395‐404. [CENTRAL: CN‐00649920; PUBMED: 18647982] ">Nurnberg 2008</a>). We have identified a larger unpublished study (<a href="./references#CD003382-bbs2-0018" title="HensleyPL , NurnbergHG , SlonimskiC , PaineS . Responders and nonresponders to sildenafil citrate therapy for SRI‐FSD. 157th Annual Meeting of the American Psychiatric Association, May 01‐06, 2004, New York, NY. 2004. NurnbergHG , HensleyPL , CroftHA , FavaM , WarnockJK , PaineS . Sildenafil citrate treatment for SRI‐associated female sexual dysfunction. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17‐22; San Francisco, CA. 2003. NurnbergHG , HensleyPL , GelenbergAJ , FavaM , WarnockJK , CroftHA , et al. Sildenafil for selective reuptake inhibitor associated female dysfunction. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23rd; Philadelphia, PA. 2002. [CN‐00429592] ">Nurnberg 2002</a>) ‐ if results from this second study were to become available, it would be expected to reduce this uncertainty substantially. </p> <p>Data from studies of bupropion 150 mg twice daily indicate a benefit over placebo. These included a study that predominantly included women (<a href="./references#CD003382-bbs2-0003" title="ClaytonAH , McGarveyEL , WarnockJ , KornsteinS , PinkertonRC . Bupropion SR as an antidote to SSRI‐induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health, 2000:Poster 169. ClaytonAH , WarnockJK , KornsteinSG , PinkertonR , Sheldon‐KellerA , McGarveyEL . A placebo‐controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor‐induced sexual dysfunction. Journal of Clinical Psychiatry2004;65:62‐7. ClaytonAL , McGarveyEL , WarnockJK , KornsteinSG , PinkertonRC . Bupropion sustained release as an antidote to SSRI‐induced sexual dysfunction. 154th Annual Meeting of the American Psychiatric Association; 2002 May 5‐10; New Orleans, LA2001:NR421. ">Clayton 2004</a>), and one solely in women (<a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a>). However, response rates in two studies of bupropion 150 mg once daily were consistent with superiority of either bupropion or placebo. The two‐point improvement in CGI taken as a measure of response in <a href="./references#CD003382-bbs2-0022" title="SafarinejadMR . Reversal of SSRI‐induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double‐blind, placebo‐controlled and randomized study. Journal of Psychopharmacology2011;25:370‐8. [CENTRAL: CN‐00738534; DOI: 10.1177/0269881109351966] ">Safarinejad 2011</a> is equivalent to an improvement in rating from 'markedly' to 'mildly' impaired function, which may be a clinically significant change. </p> </section> <section id="CD003382-sec3-0037"> <h4 class="title">Both sexes</h4> <p>Other augmentation strategies studied failed to show significant improvements in sexual dysfunction compared with placebo </p> <p>One trial involving 75 participants of both genders with sexual dysfunction due to sertraline assessed the effect of changing the antidepressant. Switching to nefazodone was significantly less likely to result in the re‐emergence of sexual dysfunction than restarting sertraline, and was not associated with any worsening of depression. However, since nefazodone is no longer available for use, this strategy is now of limited usefulness. </p> </section> <section id="CD003382-sec3-0038"> <h4 class="title">Adverse effects</h4> <p>We hypothesised that management strategies for antidepressant‐induced sexual dysfunction might differ in acceptability or be associated with a worsening of the condition for which antidepressants were originally being taken. We have identified no data for any of the strategies assessed here that indicated they led to a worsening of psychiatric symptoms. However, the relatively small numbers assessed for many of the interventions studied means that the possibility of such an effect cannot confidently be excluded in all cases. </p> <p>Rates of dropout from studies with different treatments were not clearly presented in all cases. From the available data, only one intervention was associated with an increase in people dropping out of the study, which was augmentation with mirtazapine (<a href="./references#CD003382-bbs2-0016" title="MichelsonD , KocibanK , TamuraR , MorrisonMF . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake‐associated female sexual dysfunction: a randomised, placebo controlled trial. Journal of Psychiatric Research2002;36:147‐52. ">Michelson 2002</a>). However, the analysis of this four‐arm study does not correct for the multiple statistical comparisons that result, and therefore the 95% confidence intervals presented may overestimate the confidence with which this effect has been shown. Further randomised trial data may act to reduce this uncertainty. </p> </section> </section> <section id="CD003382-sec2-0012"> <h3 class="title" id="CD003382-sec2-0012">Overall completeness and applicability of evidence</h3> <p>The available data mostly investigate the strategy of adding additional medication to counteract antidepressant‐induced sexual dysfunction. There is an absence of randomised data that assesses switching to currently‐available antidepressant agents with lower rates of sexual adverse effects, the role of psychological or mechanical interventions (<a href="./references#CD003382-bbs2-0073" title="HawtonK . Treatment of sexual dysfunctions by sex therapy and other approaches. British Journal of Psychiatry1995;167:307‐14. [MEDLINE: 7496638] ">Hawton 1995</a>), or of techniques such as drug holidays. There is a particular need for more evidence to guide treatment of antidepressant‐induced sexual dysfunction in women. The ongoing studies identified suggest that this limitation of the evidence‐base will be only partially be addressed in the foreseeable future. Of the six studies identified, only one is investigating change of antidepressant (<a href="./references#CD003382-bbs2-0051" title="Takeda Global Research &amp; Development Center, Inc . A randomized, double‐blind, parallel‐group, active‐controlled, flexible‐dose study evaluating the effect of Lu AA21004 vs escitalopram on sexual functioning in adults with well‐treated major depressive disorder experiencing selective serotonin reuptake inhibitor‐induced sexual dysfunction. ">Takeda 2011</a>), and only one other is investigating <i>Ginkgo biloba</i>, sex therapy, and a combination of the two (<a href="./references#CD003382-bbs2-0050" title="MestonC . Ginkgo biloba: antidepressant‐induced sexual dysfunction. [NCT00034021] MestonCM , RelliniAH , TelchMJ . Short‐ and long‐term effects of Ginkgo biloba extract on sexual dysfunction in women. Archives of Sexual Behavior2008;37:530‐47. [DOI: 10.1007/s10508‐008‐9316‐2; PUBMED: 18274887] ">Meston 2008</a>). </p> </section> <section id="CD003382-sec2-0013"> <h3 class="title" id="CD003382-sec2-0013">Quality of the evidence</h3> <p>Twenty‐three trials involving 1886 people were included in this review. Many studies were unclear in their reporting of methods, which leaves uncertainty regarding the extent to which their results are subject to bias (see <a href="#CD003382-fig-0002">Figure 2</a>). Use of a double‐blind design was commonly reported, but there was generally little information provided on methods used for randomisation or to maintain concealment of allocation. Studies may have been vulnerable to reporting bias, since original study protocols were not available, and, in some cases, only data from particular subscales or questions within a larger scale were reported. </p> <p>There is now a strong and internally consistent evidence base for the use of phosphodiesterase inhibitors for antidepressant‐induced erectile dysfunction in men. For women with antidepressant‐induced sexual dysfunction, the addition of bupropion at higher doses appears to be the most promising approach studied so far, however, unexplained inconsistencies in effects between studies remain, reducing the confidence with which this strategy can be advocated. </p> </section> <section id="CD003382-sec2-0014"> <h3 class="title" id="CD003382-sec2-0014">Potential biases in the review process</h3> <p>While we have made efforts to be comprehensive in our methods to identify all published studies, given the small numbers of studies that investigated most of the strategies assessed, the presence of any unpublished trials could have substantial effects on estimates of effect. In some cases, only results from particular items or subscales within ratings scales are available. It is likely that this could act to bias estimates of effect obtained, increasing apparent effectiveness. </p> <p>The investigation of multiple strategies and often multiple outcomes for each strategy within this review will have increased the risk of reporting false positive findings of effectiveness. </p> </section> <section id="CD003382-sec2-0015"> <h3 class="title" id="CD003382-sec2-0015">Agreements and disagreements with other studies or reviews</h3> <p>The Cochrane Review on the management of sexual dysfunction due to antipsychotic drug therapy similarly found some support for the addition of sildenafil in men (<a href="./references#CD003382-bbs2-0087" title="SchmidtHM ,  HagenM ,  KristonL ,  Soares‐WeiserK ,  MaayanN ,  BernerMM . Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database of Systematic Reviews2012, Issue 11. [CD003546; PUBMED: 23152218] ">Schmidt 2012</a>), but the evidence available came from only one small study (32 participants). We are not aware of any non‐Cochrane systematic reviews on this topic. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003382-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD003382-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003382-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003382-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.1 endpoint International Index of Erectile Function (IIEF) scores" data-id="CD003382-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.1 endpoint International Index of Erectile Function (IIEF) scores </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.5 endpoint Arizona Sexual Experience Scale (ASEX) total scores" data-id="CD003382-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison 1: sildenafil vs placebo, outcome: 1.5 endpoint Arizona Sexual Experience Scale (ASEX) total scores </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 3: bupropion vs placebo, outcome: 3.1 endpoint scale total scores" data-id="CD003382-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison 3: bupropion vs placebo, outcome: 3.1 endpoint scale total scores </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 3: bupropion vs placebo, outcome: 3.2 response (as defined by study)" data-id="CD003382-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison 3: bupropion vs placebo, outcome: 3.2 response (as defined by study) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 1 Endpoint International Index of Erectile Function (IIEF) scores." data-id="CD003382-fig-00101" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 1 Endpoint International Index of Erectile Function (IIEF) scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 2 Endpoint Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) scores." data-id="CD003382-fig-00102" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 2 Endpoint Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 3 Endpoint Clinical Global Impression ‐ Sexual Function." data-id="CD003382-fig-00103" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 3 Endpoint Clinical Global Impression ‐ Sexual Function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt='Comparison 1 Sildenafil vs placebo, Outcome 4 Clinical Global Impression ‐Sexual Function not "much/very much improved" by endpoint.' data-id="CD003382-fig-00104" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 4 Clinical Global Impression ‐Sexual Function not "much/very much improved" by endpoint. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 5 Endpoint Arizona Sexual Experience Scale (ASEX) total scores." data-id="CD003382-fig-00105" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 5 Endpoint Arizona Sexual Experience Scale (ASEX) total scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 6 Males: endpoint Arizona Sexual Experience Scale scores." data-id="CD003382-fig-00106" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 6 Males: endpoint Arizona Sexual Experience Scale scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 7 Endpoint MGH‐Sexual Functioning Questionnaire scores." data-id="CD003382-fig-00107" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 7 Endpoint MGH‐Sexual Functioning Questionnaire scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 8 Sexual dysfunction defined by Arizona Sexual Experience Scale at trial endpoint." data-id="CD003382-fig-00108" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 8 Sexual dysfunction defined by Arizona Sexual Experience Scale at trial endpoint. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 9 Dropouts." data-id="CD003382-fig-00109" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 9 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 10 Endpoint Hamilton Rating Scale for Depression score." data-id="CD003382-fig-00110" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 10 Endpoint Hamilton Rating Scale for Depression score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 11 Loss of remission: Hamilton Rating Scale for Depression score &gt; 9." data-id="CD003382-fig-00111" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 11 Loss of remission: Hamilton Rating Scale for Depression score &gt; 9. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 12 Global Efficacy Questionnaire (questions 1 &amp; 2)." data-id="CD003382-fig-00112" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 12 Global Efficacy Questionnaire (questions 1 &amp; 2). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 13 Global efficacy questionnaire (question 3)." data-id="CD003382-fig-00113" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 13 Global efficacy questionnaire (question 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 14 Endpoint Sexual Function Questionnaire (SFQ)." data-id="CD003382-fig-00114" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 14 Endpoint Sexual Function Questionnaire (SFQ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 15 UNM Sexual Function Inventory." data-id="CD003382-fig-00115" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 15 UNM Sexual Function Inventory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sildenafil vs placebo, Outcome 16 Females: endpoint Arizona Sexual Experience Scale scores." data-id="CD003382-fig-00116" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Sildenafil vs placebo, Outcome 16 Females: endpoint Arizona Sexual Experience Scale scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tadalafil vs placebo, Outcome 1 Global Assessment Questions." data-id="CD003382-fig-00201" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Tadalafil vs placebo, Outcome 1 Global Assessment Questions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tadalafil vs placebo, Outcome 2 Endpoint Sexual Encounter Profile (SEP)." data-id="CD003382-fig-00202" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Tadalafil vs placebo, Outcome 2 Endpoint Sexual Encounter Profile (SEP).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tadalafil vs placebo, Outcome 3 Dropouts." data-id="CD003382-fig-00203" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Tadalafil vs placebo, Outcome 3 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 1 Endpoint scale total scores." data-id="CD003382-fig-00301" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 1 Endpoint scale total scores.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 2 Response (as defined by study)." data-id="CD003382-fig-00302" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 2 Response (as defined by study).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00303"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 3 Endpoint International Index of Erectile Function (IIEF)." data-id="CD003382-fig-00303" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 3 Endpoint International Index of Erectile Function (IIEF). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00303">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00304"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 4 Endpoint Female Sexual Function Index score." data-id="CD003382-fig-00304" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 4 Endpoint Female Sexual Function Index score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00304">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00305"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 5 Endpoint Changes in Sexual Functioning Questionnaire score." data-id="CD003382-fig-00305" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 5 Endpoint Changes in Sexual Functioning Questionnaire score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00305">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00306"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 6 Dropouts." data-id="CD003382-fig-00306" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 6 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00306">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00307"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 7 Endpoint Hamilton Rating Scale for Depression score." data-id="CD003382-fig-00307" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 7 Endpoint Hamilton Rating Scale for Depression score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00307">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00308"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 8 Endpoint Clinical Global Impression (CGI ‐ SF)." data-id="CD003382-fig-00308" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 8 Endpoint Clinical Global Impression (CGI ‐ SF). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00308">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00309"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 9 Endpoint ASEX." data-id="CD003382-fig-00309" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 9 Endpoint ASEX.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00309">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00310"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 10 Endpoint EDITS (participant)." data-id="CD003382-fig-00310" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 10 Endpoint EDITS (participant).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00310">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00311"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Bupropion vs placebo, Outcome 11 Endpoint EDITS (partner)." data-id="CD003382-fig-00311" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Bupropion vs placebo, Outcome 11 Endpoint EDITS (partner).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00311">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00401"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Nefazodone vs sertraline, Outcome 1 Re‐emergence of antidepressant‐induced sexual dysfunction (physician rated)." data-id="CD003382-fig-00401" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Nefazodone vs sertraline, Outcome 1 Re‐emergence of antidepressant‐induced sexual dysfunction (physician rated). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00401">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00402"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Nefazodone vs sertraline, Outcome 2 Overall degree of sexual satisfaction (participant rated)." data-id="CD003382-fig-00402" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Nefazodone vs sertraline, Outcome 2 Overall degree of sexual satisfaction (participant rated). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00402">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00403"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Nefazodone vs sertraline, Outcome 3 Dropouts." data-id="CD003382-fig-00403" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Nefazodone vs sertraline, Outcome 3 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00403">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00404"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Nefazodone vs sertraline, Outcome 4 Hamilton Rating Scale for Depression score." data-id="CD003382-fig-00404" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Nefazodone vs sertraline, Outcome 4 Hamilton Rating Scale for Depression score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00404">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00501"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Ginkgo biloba vs placebo, Outcome 1 Endpoint sexual function ratings (investigator questionnaire)." data-id="CD003382-fig-00501" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Ginkgo biloba vs placebo, Outcome 1 Endpoint sexual function ratings (investigator questionnaire). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00501">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00502"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Ginkgo biloba vs placebo, Outcome 2 Sexual Dysfunction Scale (investigator developed)." data-id="CD003382-fig-00502" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Ginkgo biloba vs placebo, Outcome 2 Sexual Dysfunction Scale (investigator developed). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00502">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00503"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Ginkgo biloba vs placebo, Outcome 3 Dropouts." data-id="CD003382-fig-00503" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Ginkgo biloba vs placebo, Outcome 3 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00503">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00601"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Granisetron vs placebo, Outcome 1 Change from baseline on Sexual Side Effects Scale (SSES) total score." data-id="CD003382-fig-00601" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Granisetron vs placebo, Outcome 1 Change from baseline on Sexual Side Effects Scale (SSES) total score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00601">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00602"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Granisetron vs placebo, Outcome 2 Endpoint Feiger Sexual Function and Satisfaction Questionnaire score." data-id="CD003382-fig-00602" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Granisetron vs placebo, Outcome 2 Endpoint Feiger Sexual Function and Satisfaction Questionnaire score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00602">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00603"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Granisetron vs placebo, Outcome 3 Endpoint Arizona Sexual Experience Scale (ASEX) score." data-id="CD003382-fig-00603" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Granisetron vs placebo, Outcome 3 Endpoint Arizona Sexual Experience Scale (ASEX) score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00603">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00604"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Granisetron vs placebo, Outcome 4 Dropouts." data-id="CD003382-fig-00604" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Granisetron vs placebo, Outcome 4 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00604">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00605"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Granisetron vs placebo, Outcome 5 Recurrence of mood symptoms." data-id="CD003382-fig-00605" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Granisetron vs placebo, Outcome 5 Recurrence of mood symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00605">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00701"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 VML‐670 vs placebo, Outcome 1 Absence of sexual dysfunction at end point." data-id="CD003382-fig-00701" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 VML‐670 vs placebo, Outcome 1 Absence of sexual dysfunction at end point.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00701">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00702"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 VML‐670 vs placebo, Outcome 2 'Improved' or 'much improved' on Clinical Global Impression." data-id="CD003382-fig-00702" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 VML‐670 vs placebo, Outcome 2 'Improved' or 'much improved' on Clinical Global Impression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00702">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00703"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 VML‐670 vs placebo, Outcome 3 Change in Arizona Sexual Experiences Scale (ASEX) item scores." data-id="CD003382-fig-00703" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 VML‐670 vs placebo, Outcome 3 Change in Arizona Sexual Experiences Scale (ASEX) item scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00703">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00704"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 VML‐670 vs placebo, Outcome 4 Dropouts." data-id="CD003382-fig-00704" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 VML‐670 vs placebo, Outcome 4 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00704">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00801"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Buspirone vs placebo, Outcome 1 Change in patient‐rated visual analogue scales." data-id="CD003382-fig-00801" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Buspirone vs placebo, Outcome 1 Change in patient‐rated visual analogue scales. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00801">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00802"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Buspirone vs placebo, Outcome 2 Dropouts." data-id="CD003382-fig-00802" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Buspirone vs placebo, Outcome 2 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00802">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-00901"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Bethanecol vs placebo, Outcome 1 Visual analogue scale of orgasmic function ‐ best score achieved." data-id="CD003382-fig-00901" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Bethanecol vs placebo, Outcome 1 Visual analogue scale of orgasmic function ‐ best score achieved. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-00901">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Olanzapine vs placebo, Outcome 1 Change in patient rated assessment of sexual function." data-id="CD003382-fig-01001" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Olanzapine vs placebo, Outcome 1 Change in patient rated assessment of sexual function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Olanzapine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales)." data-id="CD003382-fig-01002" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Olanzapine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Olanzapine vs placebo, Outcome 3 Dropouts due to adverse effects." data-id="CD003382-fig-01003" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Olanzapine vs placebo, Outcome 3 Dropouts due to adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Mirtazapine vs placebo, Outcome 1 Change in patient rated assessment of sexual function." data-id="CD003382-fig-01101" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Mirtazapine vs placebo, Outcome 1 Change in patient rated assessment of sexual function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Mirtazapine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales)." data-id="CD003382-fig-01102" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Mirtazapine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Mirtazapine vs placebo, Outcome 3 Endpoint modified Kinsey Structured Interview." data-id="CD003382-fig-01103" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Mirtazapine vs placebo, Outcome 3 Endpoint modified Kinsey Structured Interview. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Mirtazapine vs placebo, Outcome 4 Dropouts." data-id="CD003382-fig-01104" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Mirtazapine vs placebo, Outcome 4 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Yohimbine vs placebo, Outcome 1 Change in patient rated assessment of sexual function." data-id="CD003382-fig-01201" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Yohimbine vs placebo, Outcome 1 Change in patient rated assessment of sexual function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Yohimbine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales)." data-id="CD003382-fig-01202" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Yohimbine vs placebo, Outcome 2 Change in diary ratings (visual analogue scales). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Yohimbine vs placebo, Outcome 3 Dropouts." data-id="CD003382-fig-01203" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Yohimbine vs placebo, Outcome 3 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Amantadine vs placebo, Outcome 1 Change in patient‐rated visual analogue scales." data-id="CD003382-fig-01301" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Amantadine vs placebo, Outcome 1 Change in patient‐rated visual analogue scales. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Amantadine vs placebo, Outcome 2 Dropouts." data-id="CD003382-fig-01302" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Amantadine vs placebo, Outcome 2 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01401"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 ephedrine vs placebo, Outcome 1 Endpoint Brief Index of Sexual Functioning for Women (BISF‐W)." data-id="CD003382-fig-01401" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 ephedrine vs placebo, Outcome 1 Endpoint Brief Index of Sexual Functioning for Women (BISF‐W). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01401">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01501"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Maca root: high vs low dose, Outcome 1 Endpoint Arizona Sexual Experiences Scale (ASEX) score." data-id="CD003382-fig-01501" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Maca root: high vs low dose, Outcome 1 Endpoint Arizona Sexual Experiences Scale (ASEX) score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01501">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01502"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Maca root: high vs low dose, Outcome 2 Endpoint MGH‐SFQ." data-id="CD003382-fig-01502" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Maca root: high vs low dose, Outcome 2 Endpoint MGH‐SFQ.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01502">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01503"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Maca root: high vs low dose, Outcome 3 Dropouts." data-id="CD003382-fig-01503" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Maca root: high vs low dose, Outcome 3 Dropouts.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01503">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003382-fig-01504"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/urn:x-wiley:14651858:media:CD003382:CD003382-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_t/tCD003382-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Maca root: high vs low dose, Outcome 4 Endpoint ratings of psychiatric symptoms." data-id="CD003382-fig-01504" src="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Maca root: high vs low dose, Outcome 4 Endpoint ratings of psychiatric symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-fig-01504">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/media/CDSR/CD003382/image_n/nCD003382-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003382-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sildenafil versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sildenafil compared with placebo for antidepressant‐induced sexual dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with antidepressant‐induced sexual dysfunction </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> sildenafil </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (no of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Sildenafil</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) total scores</b> </p> <p>(The IIEF is a self‐report measure with 15 questions examining erectile function, orgasmic function, sexual desire, and intercourse satisfaction. Maximum possible score 75) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IIEF score ranged across control groups from <br/> 40.9 to 44.2 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IIEF score in the intervention groups was <br/> 19.36 higher (15.00 to 23.72 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 men <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) scores ‐ question 3: ability to achieve erection</b> </p> <p>(Maximum score 5)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in control groups was 3.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention groups was <br/> 1.04 higher (0.65 to 1.44 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>231 men <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint International Index of Erectile Function (IIEF) scores ‐ intercourse satisfaction (questions 6, 7, 8)</b> </p> <p>(Maximum score 15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the control group was 7.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention group was <br/> 3.50 higher (2.48 to 4.52 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89 men <br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clinical Global Impression ‐Sexual Function not "much/very much improved" by endpoint</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Male population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 0.44 (0.33 to 0.58) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>187 <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>956 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>459 per 1000</b> <br/> (325 to 630) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Female population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>735 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>287 per 1000</b> <br/> (176 to 456) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Dropouts</b> </p> <p>(People leaving the trial early)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR</b> 0.68 (0.41 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>353 <br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (37 to 103) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b> <br/> (102 to 285) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>360 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> <br/> (148 to 411) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Global Efficacy Questionnaire (questions 1 &amp; 2)</b> </p> <p>(Questions assessing improvement attributed to medication compared to having no treatment at all) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Improvement in erections</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 2.50 (1.67 to 3.73) </p> <p>and</p> <p><b>RR</b> 2.55 (1.71 to 3.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>284 men <br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>282 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>705 per 1000</b> <br/> (470 to 1000) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Improvement in ability to have sexual intercourse</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>282 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>719 per 1000</b> <br/> (482 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The evidence for effects based on single trials is rated as moderate quality since further trial data may well change the estimate. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sildenafil versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003382-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Bupropion versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Bupropion compared with placebo for antidepressant‐induced sexual dysfunction</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with antidepressant‐induced sexual dysfunction </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> bupropion (doses of 150 mg daily and 150 mg twice daily) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (no of studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Bupropion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endpoint scale total scores (150 mg twice daily dose)</b> </p> <p>(Scales of sexual functioning. As studies used different scales to assess sexual functioning, differences are expressed as standardised mean differences (SMD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean value with this analysis is in effect zero</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the intervention groups was 1.60 higher (1.40 to 1.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>482 <br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>50% reduction in score on the Arizona Sexual Experiences Scale (ASEX) (150 mg once daily dose)</b> </p> <p>(The ASEX is a 5‐item self‐report inventory of sexual function)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Lower risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 0.62 (0.09 to 4.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>71 <br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝ <br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (4 to 208) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Higher risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (6 to 296) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Dropouts</b> </p> <p>(People leaving the trial early)</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Lower risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR</b> 1.08 (0.67 to 1.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>579 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕ <br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> <br/> (60 to 155) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Higher risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b> <br/> (100 to 258) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Unexplained inconsistency in effects between studies reduces confidence in this effect </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Bupropion versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/full#CD003382-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sildenafil vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Endpoint International Index of Erectile Function (IIEF) scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.36 [15.00, 23.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Erectile function (questions 1‐5,15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [7.39, 12.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Question 3: ability to achieve erection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.65, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Question 4: ability to maintain erection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.78, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Intercourse satisfaction (questions 6, 7, 8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.50 [2.48, 4.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Orgasmic function (questions 9, 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [1.36, 3.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Sexual desire (questions 11, 12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐0.38, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Overall satisfaction (questions 13,14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [0.86, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Endpoint Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endpoint Clinical Global Impression ‐ Sexual Function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical Global Impression ‐Sexual Function not "much/very much improved" by endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.33, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Males</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.34, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Females</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.24, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Endpoint Arizona Sexual Experience Scale (ASEX) total scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.65 [‐3.86, ‐1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Males</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.62 [‐6.29, ‐2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Females</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐2.24, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Males: endpoint Arizona Sexual Experience Scale scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.62 [‐6.29, ‐2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.08, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.06, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Erectile function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐1.66, ‐0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Orgasm (ability)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐1.90, ‐0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Orgasm (satisfaction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐1.58, ‐0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Endpoint MGH‐Sexual Functioning Questionnaire scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Erectile function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Orgasm (ability)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Sexual dysfunction defined by Arizona Sexual Experience Scale at trial endpoint <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.41, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Endpoint Hamilton Rating Scale for Depression score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐1.94, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Loss of remission: Hamilton Rating Scale for Depression score &gt; 9 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Global Efficacy Questionnaire (questions 1 &amp; 2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.53 [1.90, 3.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Improvement in erections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [1.67, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Improvement in ability to have sexual intercourse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.71, 3.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Global efficacy questionnaire (question 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.65, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Question 3: Frequency of erection that allowed satisfactory sexual intercourse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.65, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Endpoint Sexual Function Questionnaire (SFQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Arousal‐sensation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Arousal‐lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.5 Enjoyment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.6 Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.7 Partner</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 UNM Sexual Function Inventory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Sexual arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.5 Ability to reach orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.6 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Females: endpoint Arizona Sexual Experience Scale scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 Orgasm (ability)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5 Orgasm (satisfaction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.6 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sildenafil vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Tadalafil vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global Assessment Questions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Has the treatment you have been taking improved your erectile function?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.5 [3.03, 43.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Has the treatment improved your ability to engage in sexual activity?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.5 [3.03, 43.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Endpoint Sexual Encounter Profile (SEP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Question 2:  Were you able to insert your penis into your partner's vagina?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.68, 8.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Question 3: Did your erection last long enough for you to have successful intercourse?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.78, 46.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Question 4: Were you satisfied with the hardness of your erection?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.78, 46.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Question 5: Were you satisfied overall with this sexual experience?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.78, 46.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Lack of efficacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Tadalafil vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Bupropion vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Endpoint scale total scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [1.40, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 International Index of Erectile Function (IIEF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [1.45, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Female Sexual Function Index (FSFI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [1.41, 2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Changes in Sexual Functioning Questionnaire (CSFQ)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐0.11, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Response (as defined by study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>31.77 [10.10, 99.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50% reduction Arizona Sexual Experiences Scale (ASEX)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.09, 4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Clinical Global Impression (CGI‐SF) 2‐point improvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>186.73 [11.74, 2969.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endpoint International Index of Erectile Function (IIEF) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.10 [17.14, 23.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Erectile function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.30 [8.18, 10.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Orgasmic function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.70 [2.15, 3.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.76, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Intercourse satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.6 [3.00, 4.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [1.99, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Endpoint Female Sexual Function Index score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Endpoint Changes in Sexual Functioning Questionnaire score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Desire/interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Desire/frequency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Arousal/excitement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Completion/orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.67, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Endpoint Hamilton Rating Scale for Depression score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Endpoint Clinical Global Impression (CGI ‐ SF) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐1.87, ‐1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Male</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.5 [‐1.80, ‐1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Female</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐1.95, ‐1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Endpoint ASEX <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Erectile function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5 Ability to reach orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.6 Satisfaction with orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Endpoint EDITS (participant) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Expectations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 Likelihood of continuing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5 Confidence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6 Partner satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7 Partner desire to continue treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.8 Naturalness of achieving erection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.9 Naturalness of erection hardness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.10 Quickness of achieving erection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.11 Duration that erection lasts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.12 Ease of use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Endpoint EDITS (partner) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 Expectations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 Sexual desirability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5 Participant's feelings about continuing treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6 Duration that erection lasts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Bupropion vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Nefazodone vs sertraline</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Re‐emergence of antidepressant‐induced sexual dysfunction (physician rated) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Week 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Endpoint</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Overall degree of sexual satisfaction (participant rated) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Week 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Last rating recorded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Attributed to adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hamilton Rating Scale for Depression score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Week 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Nefazodone vs sertraline</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Ginkgo biloba vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Endpoint sexual function ratings (investigator questionnaire) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Overall sexual function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Erection maintenance time</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Orgasm frequency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Satisfaction to orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Sexual Dysfunction Scale (investigator developed) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Week 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Ginkgo biloba vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Granisetron vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change from baseline on Sexual Side Effects Scale (SSES) total score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Endpoint Feiger Sexual Function and Satisfaction Questionnaire score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Item 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Item 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Item 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Item 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Item 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Item 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endpoint Arizona Sexual Experience Scale (ASEX) score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Orgasm (ability)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Orgasm (satisfaction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Recurrence of mood symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.12, 66.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Granisetron vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">VML‐670 vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Absence of sexual dysfunction at end point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.86, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 'Improved' or 'much improved' on Clinical Global Impression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.71, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in Arizona Sexual Experiences Scale (ASEX) item scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.19, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 How strong is your sexual drive?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.36, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 How easily are you sexually aroused?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.47, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Females: how easily does your vagina become moist or wet?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.22, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Males: can you easily get and keep an erection?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.4 [‐0.80, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 How easily can you reach orgasm?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.28, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Are your orgasms satisfying?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.22, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.73, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.56, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Attributed to adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.75, 7.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">VML‐670 vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Buspirone vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in patient‐rated visual analogue scales <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall function (total of interest, lubrication, orgasm, pleasure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [‐38.33, 44.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐7.61, 9.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.30 [‐3.88, 14.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Interest/desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.70 [‐7.99, 13.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.90 [‐3.65, 23.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.3 [‐19.98, 7.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Pleasure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.20 [‐15.53, 9.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [‐3.15, 17.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Buspirone vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Bethanecol vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Visual analogue scale of orgasmic function ‐ best score achieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Bethanecol vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Olanzapine vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in patient rated assessment of sexual function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in diary ratings (visual analogue scales) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Overall sexual function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Physical arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Pleasure/enjoyment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9 Discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts due to adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Olanzapine vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Mirtazapine vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in patient rated assessment of sexual function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in diary ratings (visual analogue scales) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Overall sexual function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Physical arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Pleasure/enjoyment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9 Discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endpoint modified Kinsey Structured Interview <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.19, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Sexual satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.19, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Attributed to adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Mirtazapine vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Yohimbine vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in patient rated assessment of sexual function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in diary ratings (visual analogue scales) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Overall sexual function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Sexual interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Psychological arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Physical arousal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Pleasure/enjoyment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9 Discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Attributed to adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Yohimbine vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Amantadine vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in patient‐rated visual analogue scales <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall function (total of interest, lubrication, orgasm, pleasure)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.0 [‐29.02, 55.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.1 [1.23, 14.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.7 [5.30, 20.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Interest/desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐7.96, 9.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.90 [‐5.74, 21.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Orgasm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [‐11.91, 16.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Pleasure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐11.28, 14.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Discomfort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐11.25, 13.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Amantadine vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">ephedrine vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Endpoint Brief Index of Sexual Functioning for Women (BISF‐W) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sexual arousability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Lack of vaginal lubrication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Orgasm ability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Orgasm intensity/pleasure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Sexual dissatisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">ephedrine vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003382-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Maca root: high vs low dose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Endpoint Arizona Sexual Experiences Scale (ASEX) score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Question 1: Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Endpoint MGH‐SFQ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Total score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Item a: Sexual desire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.60, 3.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Endpoint ratings of psychiatric symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Hamilton Depression Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.5 [‐7.98, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Hamilton Anxiety Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐3.15, 2.35]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Maca root: high vs low dose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003382.pub3/references#CD003382-tbl-0017">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003382.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003382-note-1206">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD003382-note-1205">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD003382-note-1204">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003382\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003382\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003382\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003382\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003382\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003382.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003382.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003382.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003382.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003382.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729608397"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003382.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729608401"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003382.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee10d08659377',t:'MTc0MDcyOTYwOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 